University of Windsor

Scholarship at UWindsor
International Joint Commission (IJC) Digital
Archive

International Joint Commission

1981-03-20

Workshop on the Compatibility of Great Lakes Basin Cancer
Registries: Proceedings. Held March 19-20, 1981, Windsor,
Ontario: Report
Committee on the Assessment of Human Health Effects of Great Lakes Water Quality
Great Lakes Science Advisory Board

Follow this and additional works at: https://scholar.uwindsor.ca/ijcarchive

Recommended Citation
Committee on the Assessment of Human Health Effects of Great Lakes Water Quality, & Great Lakes
Science Advisory Board (1981). Workshop on the Compatibility of Great Lakes Basin Cancer Registries:
Proceedings. Held March 19-20, 1981, Windsor, Ontario: Report. International Joint Commission (IJC)
Digital Archive. https://scholar.uwindsor.ca/ijcarchive/281

This Report is brought to you for free and open access by the International Joint Commission at Scholarship at
UWindsor. It has been accepted for inclusion in International Joint Commission (IJC) Digital Archive by an
authorized administrator of Scholarship at UWindsor. For more information, please contact
scholarship@uwindsor.ca.

Report to the
Great Lakes Water Quality Board / Great Lakes Science Advisory Board

proceedings of the

Workshop on the compatibility of
Great Lakes Basin Cancer Registries
held March 19 ~20, 1981

Windsor, Ontario

sponsored by the
International Joint Commission s
Great Lakes Water Quality Board and
Great Lakes Science Advisory Board
through their

Committee on the
A
Assessment of Human Health Effects of
Great Lakes Water Quality

Notice
Statements and views presented in these
Proceedings

are those of the
workshop participants and do not necessarily refle
ct the views and policies of
the International Joint Commission or those
of its Water Quality Board or
Science Advisory Board and Committees. Mention
of trade names or commercial
products does not constitute endorsement or recommenda
tion for use.

Table of Contents
PAGE

NOTICE
LIST OF TABLES
PREFACE AND ACKNOWLEDGEMENTS

vii

THE INTERNATIONAL JOINT COMMISSION, CANADA

UNITED STATES

ix

1.0

INTRODUCTION

'

2.0

SUMMARY

3.0

RECOMMENDATIONS

4.0

GREAT LAKES BASIN CANCER REGISTRY CHARACTERISTICS

5.0

DATA UTILIZATION FOR RESEARCH

11

6.0

FUTURE DEVELOPMENTS

15

APPENDICES
A.

Approach to the Workshop - Agenda, Participants
and Work Groups

17

B.

"Activities of the IJC Committee on the Assessment of
Human Heaith Effects of Great Lakes Water Quaiity An Overview", by Dr. G.C. Becking, HeaTth and Weifare,
Canada

25

C.

"Water Contamination by Toxic ChemicaTs: A Chaiienge to
Cancer Registries in Assessing Popuiation Risks", by

29

Dr. R.F. Spengier, The Ontario Cancer Treatment and

Research Foundation

D.

"Cancer Mortaiity and Drinking Water Quaiity in Seiected

39

E.

"Coion Cancer in Watertown, New York",

59

F.

Cancer Registry Survey, Compieted Questionnaires by
the Great Lakes Basin Cancer Registries

65

G.

Great Lakes Project - Dr. Leonard Schuman, University

Preiiminary Resuits", by
Canadian Municipaiities:
Drs. D.T. Wigie, Y. Mao, P. Toft and J.C. Meranger,
Heaith & Weifare, Canada

by Dr. w.S. Burnett, New York State Department of Heaith

of Minnesota, (U.S. EPA Funding)

107

(cont'd) TABLE OF CONTENTS
PAGE

H.

I.

Fier Studies of Se1ected Popu1ations Dr. Haron E.B. Humphrey, Michigan Department
of Pub1ic HeaTth

111

ttee
Membership and Terms of Reference for the IJC Commi

115

Great Lakes
on the Assessment of Human Hea1th Effects of

Water QuaTity

iv

List of Tables
PAGE
Data Elements Collected in Each of the Cancer Registries
within the Great Lakes Basin

10

APPENDIX C
Selected Health Outcomes to Assess Water Contaminants

32

Cancers Associated with Water Contamination

33

APPENDIX D
Pearson Correlation Coefficients Between Demographic and
Water Quality Variables

44

Pearson Correlation Coefficients Between Selected
Demographic and Water Quality Variables and
Age-Standardized Mortality Rates (Age 25-69)

46

Age-Standardized Mortality Rates (Age 35-69) for

47

Age-Standardized Mortality Rates (Age 25-69) for Localities
Ranked by Asbestos Concentration in Water Distribution System

48

Age-Standardized Mortality Rates (Age 35 69) for Sherbrooke

50

Water Quality Mortality Study:

51

Municipalities Grouped by Water Quality Characteristics

and Comparison Localities

Multiple

Regression

Analysis, Beta Coefficients (Least-Wise Deletion, 28 Cities)

Preface and Acknowledgements
These Proceedings present the findings of the Workshop on the
Compatibility of Great Lakes Basin Cancer Registries on March 19-20,
1981 in Windsor,
Ontario. The Workshop was sponsored by the IJC Committee on the
Assessment of
Human Health Effects of Great Lakes Water Quality on behalf of
the Great Lakes
Water Quality Board and the Great Lakes Science Advisory Board of the
IJC
under the Commission's authority to implement the terms of the Great Lakes
Water Quality Agreement of 1978.
The Workshop was an initial step in implementing the Health
Effects

Committee's intent to ensure compatibility for cancer data collection
and

handling methodologies in the Great Lakes Basin.

objectives were addressed at the workshop by
the corresponding Work Groups:

0
0
0

The following major

the participants, divided into

cancer registry characteristics;
data utilization for research; and
future developments.

The Workshop Recommendations were drafted by the Work Groups and

formalized by the participants.
presented in Section 3.0.

The recommendations from the Proceedings are

The Human Health Effects Committee expresses its gratigude to the Workshop
organizers, and to the 19 participants listed in Appendix A, who contributed
valuable time and expertise. The Committee is indebted to Dr. Robert F.
Spengler, Workshop Chairman and to Dr. Andrew E.P. Watson, Workshop Secretary,
who carefully compiled and prepared these proceedings. Gratitude is also
expressed to those members of the IJC Great Lakes Regional Office, Windsor who

made significant contributions to the Workshop and assisted in the preparation
of the Proceedings.
In the interest of condensing the Proceedings for the reader, the formal
presentations made by Drs. Becking, Spengler, Wigle and Burnett have been
placed in separate appendices. If they had been included in the text, they

would have overpowered (in subject and length) the cancer registry material.

A sumnary of these interesting presentations would not have done justice to
their topic, so readers are encouraged to read these particular appendices:
B:

Dr. G.C. Becking - "Activities of the IJC Committee on the Assessment
of Human Health Effects of Great Lakes Water Quality - An OverView"

C:

Dr. R.F. Spengler - "Water Contamination by Toxic Chemicals: A
Challenge to Cancer Registries in Assessing Population Risks"

D:

E:

Dr. D.T. Wigle - "Cancer Mortality and Drinking Water Quality in

Selected Canadian Municipalities:
Dr. W.S. Burnett

Preliminary Results"

"Colon Cancer in Watertown, New York"
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International Joint Commission , Canada ~United States
The InternationaT Joint Commission (IJC) was estabTished under the
Boundary Waters Treaty of 1909. It consists of six Commissioners, three from
Canada and three from the United States. A Commissioner from each country is
a Co Chairman. The Commissioners act as a singTe body seeking common
soiutions, with decision reached by majority.

The Treaty was estabiished to aid in settTing and preventing disputes
regarding the use of boundary waters, by means of joint deiiberations of the
Commission. Headquarters of the Commission are Tocated in Ottawa, Ontario and
in Washington, D.C., for the Canadian and United States Sections, respectiveiy.
Three categories of Commission responsibiTity derive from the 1909 Treaty:

0
o
o

decisions regarding the approvai of appTications for the use,
obstruction or diversion of boundary waters or of works affecting
boundary water TeveTs;
undertaking investigations and studies of specific probTems aTong the
common frontier when requested by one or both Governments as a
Reference; and
decisions on questions or matters of difference referred by the

Governments.

The internationai advisory Boards assist the Commission by organizing and
preparing required technicaT studies and fier work. Board reports to the
Commission are made pubiic and pubTic hearings are her so that individuaTs,
organizations and governments may conment. The resuTting information together
with the Board report, is used when the Commission reports to both Governments
with its recommendations. These reports are aTso made pubTic.
In 1972 the Great Lakes Water QuaTity Agreement was signed by both
countries. After extensive review a new Agreement was signed in 1978, to
restore and enhance the water quaTity of the Great Lakes. The Governments
have given to the Commission specific responsibiiities and functions to assist
them in the impTementation of the Agreement. Inciuded in these responsibiTities is the requirement to tender advice and recommendations. The
Agreement aTso provided for two internationaT boards to assist the Commission,

the Great Lakes Water Quality Board and the Science Advisory Board.
Secretariat functions are provided by the IJC Regionai Office, estabiished
under the Agreement in Windsor, Ontario in 1973.
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I . Introduction
The Great Lakes Basin encompasses a vast geographic area and contains the
world's largest system of freshwater lakes. In addition to the natural
splendor of this resource, the availability of water and transportation has
attracted settlement in the region over the past two centuries. Over 37
million people work and reside in the Great Lakes Basin which today contains
major industrial and manufacturing centers, large agricultural regions, sport

and commercial fishing, urban centers and an extensive water transportation

network.

It is well recognized that society has had an impact on the

environment of the Great Lakes Basin. One aspect which has achieved
increasing interest is the presence of chemical contaminants in the
environment from the manufacture, application or disposal of chemicals.
The 1978 Water Quality Agreement recognized the significance of toxic
transboundary pollutants and cited the need to develop strategies to
understand and eliminate such contaminants from the Great Lakes Basin
ecosystem in order to protect human health. Concern for the possible

consequences of human exposure to persistent chemical contaminants can be
ng
realized from the mandates dealing with toxic problem anticipation, monitori

and research which are found in annex 12 of the Agreement. Human health
t.
protection represents a key element in the Great Lakes Water Quality Agreemen
Over 380 chemical contaminants have been identified in one or more areas
of the Great Lakes Basin ecosystem. Relating such a mix of chemicals to human
disease is a formidable task. The potential human health impact is unknown or
poorly understood for many of the contaminants. In an effort to identify

e on the
those contaminants of particular concern to human health, the Committe

Assessment of Human Health Effects of Great Lakes Water Quality has been
reviewing the available toxicological information on these chemicals for the
past two years. The Committee has found that acute and chronic toxicity data
exist only on a small number of these chemical contaminants. The remaining
chemicals are either of minimal concern (because of assumed low concentrations
in the environment) or not categorized (because insufficient data exist to

permit a hazard assessment). Although not finalized, these groupings provide
a focus for further activities related to surveillance and remedial actions.
Classification of identified chemical contaminants on the basis of
potential human toxicity raises questions regarding possible health impacts
of
from present or past exposures. Whether or not these chemicals or some mix
certain
in
cancer
as
them have or will cause chronic or long term disease such
lt
p0pulation groups is a complex question. Addressing the problem is difficu
and
exposed
because of the very large number of people who may be potentially
the many confounding variables which might in themselves be related to the
and
development of disease such as socio-economic status, life style elements

occupation.

In order to evaluate the significance of chemical pollutant contaminants
of
identified in the Great Lakes Basin and understand the human implications
events
exposure it is necessary to establish a mechanism for monitoring health
such as
which occur in the basin population. A registry of major life events
cancer and death could provide a foundation for identifying populations at
greater risk of disease.

The Workshop on the Compatibility of Great Lakes Basin Cancer Registries
represents a first step towards integrating data coiiection systems on a
basin-wide basis. Empioyment of uniform data requirements woqu aTTow the
exchange and utiTization of cancer data coTTected by the various jurisdictions
in the Great Lakes Basin. Such data coqu be used to assess trends or
identify areas with high cancer rates within the Great Lakes Basin. The
cancer registry data may be usefuT in assessing the impact of toxic
contaminants on the population residing within the region.

The cancer

registry analyses woqu further assist the pTanning and conduct of
epidemiologicai investigations, toxicoiogicai research, human exposure
evaTuations and environmentaT monitoring. One purpose of an integrated
to
disease registry system woqu be the evaTuation of cancer risks in reTation
s.
environmentaT exposures from toxic chemicaT

2. Summary
One means of assessing the chronic and carcinogenic effects of toxic
chemicals in the Great Lakes Basin is a detailed evaluation of cancer rates in
the population residing in this region. Rates of cancer development can only
be determined by the registration of newly diagnosed cancers in a defined'
geographic area and using population census information for the same area.The ability to identify new cases of cancer for research studies, to monitor

trends in cancer rates and to locate regions with unusually high rates of

cancer, is contingent upon complete and accurate registration of cancer.

conplete review of cancer incidence in the Great Lakes Basin is also
contingent upon the population coverage and the compatibility of cancer
registries.

A

A workshop on the compatibility of Great Lakes Cancer Registries was
initiated by the Health Effects Committee and held on March 19-20, 1981.

Great
Participants were representatives of the cancer registries within the
d at
addresse
were
es
objectiv
major
The
Lakes Basin and invited guest experts.
for
ion
utilizat
data
ristics;
the Workshop: cancer registries' characte

research; and future developments (Appendix A).

Total coverage of the Great Lakes population is not yet complete in cancer

registration.

The cancer registries in the states of Illinois (a pilot four

hospital registry), Michigan (a pilot pathology reporting system), Ohio
a pilot
(reporting in Montgomery County only) and Pennsylvania (beginning
to
support
ed
registry system) are not fully developed and require continu
not
does
y
achieve statewide implementation. A statewide cancer registr
currently exist in Minnesota. The remaining States and Ontario have had
years. The
cancer registries covering their total populations for a number of
on
based
method of registration was not uniform and some registries were
s of
method
gh
pathology reports, hospitalized cases of cancer or more thorou
also
case ascertainment. Different methods of data collection and coding
ries. However,
affect the compatibility of cancer information between regist
s,
all registries were collecting the essential information on cancer patient
sis,
diagno
of
date
e.g. name, address or area of residence, birth date, sex,
is.
diagnos
of
method
site of cancer, histology and

dependent upon
The utility of cancer registry data for research is highly
e and
the quality of data, completeness of registration, population coverag
n
betwee
exist
which
s
rence
diffe
The
.
method of data collection and coding
ries.
regist
l
severa
from
data
ing
registries may create problems in combin
es of cancer rates were
However, these problems would be minimized when analys
ctions.
conducted only within specific registry jurisdi
on the toxic
The participants recognized that insufficient information
specific
levels,
n
tratio
chemicals in the Great Lakes Basin (notably concen
ng of
planni
the
hamper
would
s)
locations and lack of presumed health effect
of
types
l
Severa
ries.
any specific studies conducted by the cancer regist
ntly
curre
using
ted
conduc
be
studies identifying high cancer rate areas could
made
also
ipants
partic
available cancer morbidity and mortality data. The
information
specific recommendations as to the types of toxic chemical
es and the
outcom
desired, the focus of additional research on non-cancer
exposures.
l
nmenta
utilization of human tissues or fluids to assess enviro

The workshop provided a unique opportunity for cancer registry
representatives and invited experts to exchange usefui information on
registration practices and cancer research in Canada and the United States.
The meeting accompiished the goais which were initiaiiy set out and the forum
created new professiona] contacts which wiii enhance cancer registry
interaction and may induce further compatibiiity in the years ahead. The
cancer registries wii] be wiiiing and abie to undertake specific research
projects.

3 . Recommendations
1. In order to estabiish a means of evaTuating the environmentaT hazards and

potentiaT cancer risks in the Great Lakes water basins, it is strongTy
recommended that the coTiection of popuTation-based, cancer incidence data
be supported by the U.S. states bordering the Great Lakes and the Province
of Ontario, Canada. The current deveTopment of cancer surveiTTance
systems for the states of ITTinois, Indiana, PennsyTvania and Ohio shoqu
be encouraged. The remaining states and Ontario require continuing
support.

There shoqu be a TegaT provision for the interchange of cancer case data
treated
between reTevant jurisdictions when cancer cases are diagnosed or
e.
residenc
usuai
of
outside their state or Province

It is recommended that the IJC prepare a detaiied document of the
identified toxic chemicaTs or substances in the Great Lakes water basins,

(through water,
their potentiaT heaith effects, their sources of exposure
ration)
concent
ing
(incTud
ution
fish, sediment or air) and their distrib

of
within the water basins. Such a document wiTT assist the pianning
changes
ng
measuri
for
index
usefuT
future heaTth research and serve as a
from controi programs.

data
It is reconmended that the IJC assembTe the avaiTabTe water quaiity
of
tiers
two
the
for each of the major municipai water suppiies within
U.S. and Canadian counties bordering the Great Lakes.
Purpose

" 0
0
0
0

gaps in
To identify Water contaminants, regional variation and

available data resources.
.
Define the population served by each water supply
facility.
each
for
dures
proce
ent
treatm
and
(s)
source
Identify
(e.g. change of
Obtain information on major historical changes
on and filtration).
source, introduction of fluoridation, chlorinati

standardized
A water quaTity survey shoqu be conducted, utiTizing
tiers of U.S.
methods, on the water distribution systems serving the two
and Canadian counties bordering the Great Lakes.
Purpose
0

water quality,
To obtain a more complete assessment of drinking
ures.
proced
utilizing modern and standardized

Details

0

0

0

period to allow
Samples should be collected over a sufficient time
y.
qualit
for seasonal variations in water
the treatment facilities
Samples of treated water shOuld be taken at
defined later).
be
(to
and analyzed for major toxic chemicals

ses and mutagenicity
The evaluation should utilize both chemical analy
tests.

0

Consideration should be given to analysing drinking water samples in
order to obtain data fer water that is consumed.

6. It is recommended that detailed mortality maps be produced, focussing on

cancer, for those counties bordering on the U.S. and Canadian sides of the
Great Lakes and the St. Lawrence River as far east as Cornwall.
Purpose
0

To identify high-risk regions within the Great Lakes Basin which
could be subjected to further investigation.

Details

0

a
0
0

Data would be assessed for time trends since 1950 to the most recent

years.
Included in this geographic analysis would be the first two "tiers"
of counties bordering the lakes.
The analysis would use an appropriate reference population for
comparison.
Consideration should be given to analyze cancer mortality at the
municipality level.

It is recommended that existing cancer incidence data be analyzed to
determine if excessive rates of cancer can be identified in the geographic
regions of the Great Lakes water basins.
If recomnendations 3 through 6 are accomplished, it should then be
Further assessment
possible to evaluate potential human health effects.

of perceived health risks would require prospective or retrospective
epidemiological studies.

It is recommended that the IJC and respective
research in the following areas:

a)

b)
c)

government agencies foster

Health studies of human populations consuming fish taken from the

Great Lakes water basins;

Animal feeding studies using concentrates of treated drinking water
supplies; and
The use of human tissues in assessing exposure to environmental

contaminants (eg. adipose tissue, breast milk, umbilical cord blood

or products of birth).

10. Consideration should be given to utilizing or developing a surveillance
system of selected birth defects or adverse pregnancy outcomes for the

assessment of human health effects that may be related to toxic chemical
exposure.

ll. The state or provincial cancer registries should endeavour to identify

high risk areas within their jurisdictions through constant surveillance
and investigation of cancer occurrence.

12. It is recommended that periodic updates be made to ensure that the
workshop objectives are being addressed.
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4. Great Lakes Basin Cancer Registry Characteristics
Each of the cancer registries in the Great Lakes Basin outlined in detail
their method of operation in the survey questionnaires distributed prior to
the workshop (Appendix F). This section will briefly summarize the characteristics of each registry and discuss the needs for further standardization.

4.1

National Cancer Incidence Reporting System (Canada)
Since January 1, 1969, Canada has developed a population-based, national

reporting system on cancer incidence.

Each of the ten provincial

registries (British Columbia, Alberta, Saskatchewan, Manitoba, Ontario,
Quebec, New Brunswick, Nova Scotia, Prince Edward Island and

Newfoundland) supplies cancer incidence information to a central,
coordinating, data resource at Statistics Canada. A limited number of
personnel look after the analysis of the national incidence data. The
National registry covers a population of over 22 million people and had
over 75,000 new cancers (includes an Ontario estimate) diagnosed in 1978.

4.2

Illinois Cancer Council

The Illinois cancer registry consists of four hospital cancer registries
(Northwestern Memorial, Rush Presbyterian St. Luke's, University of
Chicago and University of Illinois) which have been developed since
1978. The registry started as a pilot project and is currently
investigating several approaches to a statewide surveillance system. A
population-based registry is a desirable approach but depends on the
level of resources within the state.

4.3

Michigan Cancer Incidence Reporting System
The registry has been developed from a pilot project which began on
October 1, 1980. The registry seeks pathology information from five
hospitals. The pathology reporting system will ultimately cover the
entire state of Michigan, some 9.2 million people. The reporting system
is presently manual and 1,600 newly diagnosed cases of cancer are
reported each year from the five participating hospitals.

State funding

has been sought for a statewide reporting system which will include a
staff and computer processing capabilities.

4.4

Michigan Cancer Foundation Registry
The registry was established in 1969 and provides coverage of 4.1 million
people in three counties which surround and include the city of Detroit.
New cases of cancer are identified from hospital records, physician
reports, radiation therapy facilities, death certificates or from

research studies. There were 14,717 new cases of cancer reported in
1979. The registry is mainly supported by the National Cancer Institute
and actively participates in the Surveillance, Epidemiology and End
Results (SEER) program. The registry uses a large staff to actively
collect, process and analyse the cancer information.

Active annual follow-up is also carried out on cancer patients. The
registry lS converting to a larger computer system which will improve the

processing and analysis of the cancer data base.

4.5

Minnesota Cancer Registry

No statewide or population-based registry currently exists in Minnesota.
A cancer registry may later be developed, but only several hospital-based
registries exist at present.

4.6

New York State Cancer Registry

A statewide cancer reporting system was developed in 1940 (excluding New
York City until 1973) and became automated in 1950. The registry covers
a population of over 17 million people and collects cancer information
from hospital reports, laboratories and death certificates. A staff of
15 people processes the incoming data and deals with the computerized
files. The registry handled 66,843 new cases in 1978 and is funded by
the State of New York.
4.7

Ohio State Cancer Registry (Montgomery County)
A cancer registry was developed in Montgomery County in 1953. The
registry is based on cancers reported from six hospitals within the
Since1974 each hospital registry sends reports to the central
county.
registry. The annual number of new cases has been 3,100 cases in a
county population of over 600,000 people. The registry system also
contains a means of follow-up on all cases.

4.8

Ontario Cancer Registry

The cancer incidence registry started formally in 1969 and covers a
population of 8.5 million people. New cases of cancer are identified
through a computerized linkage process using cancer information from
hospital separations; pathology reports; treatment
several sources:
centres of The Ontario Cancer Treatment and Research Foundation; death
certificates; and other hospital registries.

The annual number of new

cancers was estimated to be 27,000 in 1976. The registry is currently
creating cancer incidence data for 1972 1977. A means of active
follow-up on cancer patients exists for the treatment centres. The
registry's computer system is being upgraded to improve processing and
analysis.

4.9

Pennsylvania Cancer Registry

The cancer registry is currently in a planning stage. A pilot test will
be conducted soon before beginning a statewide operation. It is
estimated that 44,000 new cases of cancer will be identified annually.
The registry will collect information mainly from hospital and laboratory
reports.

4.10 Wisconsin Cancer Reporting System

The statewide registry began in 1978 following a pilot project in seven
by
counties. The registry is based on cancer cases being identified
8

general hospital medical records departments or tumour registries.
Active follow-up on patients is not carried out. There were 15,400 new
cancer cases identified in 1979 from a population of over 4.6 million
peop e.

4.11 Discussion
All registries were either collecting or planning to collect similar
types of basic information (Table 1) on every cancer patient: name;
address; birth date; date of diagnosis; sex; site of cancer; histology;
and method of diagnosis. Few of the registries are able to collect
clinical information:

size of tumour; regional node involvement; stage

of disease; date and type of treatment; and date of first recurrence.
was felt that the basic information provided by each registry was
sufficient for registry needs.

It

The operation of a registry requires a means of collecting and processing
cancer data in an efficient manner. Each of the registries is different
in their specific methods of registration, but all appear to have
mechanisms to assess the quality and completeness of their cancer
registration.
It would be difficult to further standardize the registries beyond the
types of data being collected. As exemplified in the brief descriptions

of each registry (4.1-4.10), it is clear that the methods of registration

developed in each jurisdiction are a result of careful planning and
cooperation. Further standardization of registries would result in
perhaps improvements in some and great resistance among the others.
method of data collection in one registry may be effective, but its
introduction into other registries might result in inefficiency or
greater expense.

The

Without the ability to standardize the methods of cancer registration,
one must be aware of the problems introduced when data is pooled or
compared among the Great Lakes Basin cancer registries, as discussed in
the next section.

TABLE 1.

WITHIN THE GREAT LAKES BASIN
DATA ELEMENTS COLLECTED IN EACH OF THE CANCER REGISTRIES
CANADA

(Statistics
DATA ELEMENTS

Y

-

Y

County)
(MCOCR)
Y

(OCTRF)
(OCR)
Y

PA

(PCR)
N

NI

(NCR)
Y
::> :» >->->->~> >->-::>-> > > >->->-::::>->-> >-::2:> >

zzmm

zmo.m ammmm mmmaa mmmam mammz

Minimum data set requirements for a cancer registry.

Y

(NYSCR)

ONT

>u>
>->->->-a.n.>->-n.>-> n.o.>->->->->->->->->->->-o.>-

*

(MCIRS)

I

Race/Nationaiity*
Marital status
Sex*
Date of initiai diagnosis*
Primary site*
Histoiogy*
Method of Diagnostic confirmation*
Paired organ invoivement
Size of tumour
Regional node invoivement
Stage at diagnosis
Date of first treatment
First course of treatment
Date of first recurrence
Subsequent treatment(s)
Date of iast contact/death*
Status (alive or dead)

DATA
N/A

OH

(Montgomery

->
>->->-> >~>->->->-> >-> > >->->->->->->-2:>->->-2:>->

Date of birth*

Age at diagnosis*

(MCFR)

NY

::::::
>->->-::CL> > >~CL> >->->-> > >-> nL2:::=:>-::::::

State/Province*
Zip/Postai Code

MN

>->->
>->->->:>>~> >->:»> > >q>> > >-> >->->->->->-2:
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City/Town/County*

MI

MI

> >->~> z>->>-> > > > z> >> > >->-zzzZzZZZZ

Maiden name*
Street address*

2:2:>->
>->->->.z;»> >-> >-2:>-z:»::> > >->-2:z:>-2:>-

First given name*
Second given name*

(ICC)
>

(for muitipie primary sites)

Last name*

:z::=:znl
z:>->->-> 2;>~> 2:>->-2:>:»> >->->->-z:z:z

Case number*

>.

Registry number*

Canada
(NCIRS)

IL

5. Data Utilization for Research
Before the utiTization of cancer data for research purposes,

it is

important to consider the data quaTity and usefuTness across the cancer
registries within the Great Lakes Basin. The future directions that severaI
registries are taking wiTI aTso be discussed. The information in this section
is summarized from the detaiied information received from each registry

(Appendix F).

5.1 Data Quaiity

SeveraT indices have been used to assess the quaTity and compTeteness of
cancer registration.1 The proportion of newTy diagnosed cases, which
to
are initiaTTy identified by death certificate onTy, is one measure used
ion
proport
equaT
an
that
assess registry compieteness. The index assumes
is used to
of cases was missed by the registration process. Another index
gicaTIy
histoIo
measure quaTity by the proportion of new cancer cases
confirmed.
accurate.

A high proportion infers that the diagnoses are reasonabTy

SeveraT registries were not abTe to supply an estimate of death
certificate onTy cases.

Of the four registries responding, three

tion of
registries were under 3% which is considered to be a good indica
which
13%
of
compTeteness. However, one registry reported an estimate
impIies that under registration may have occurred. Of the seven
Iy confirmed,
registries estimating the proportion of cases histoTogicaT
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83%
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ing a
report
ries
regist
two
were
There
histoIogicaT confirmation.
y
registr
the
when
e
possibl
onTy
is
This
confirmation rate of 100%.
Such a
cases.
cancer
new
fy
identi
to
s
echusiveTy uses pathoTogy report
than
other
methods
by
ed
diagnos
Iy
common
practice wiTI miss those cancers
tissue pathoTogy.
between
Other issues concerning data quaIity encompass the variabiIity
Coding
ces.
practi
tion
vaIida
registries in coding, verification and
same office.
practices may differ between hospitaTs or even cTerks in the
eTements
data
the
that
ensure
to
Verification requires that data be edited
sampTe
a
on
y
usuaIT
es,
requir
are indeed coded correctTy. VaTidation
the originaI source
basis, the comparison of compTeted registry data with
te.
to ensure that the information is totaTTy accurate and compTe

of registry quaTity
The data coTTection practices and the crude measures
data
sed when using
and compIeteness indicate that caution must be exerci

concerns are reduced
from severaT registries for research purposes. Such
has continued
that
on
when research is carried out within one jurisdicti
the same registration practice for many years.

1

nationaI Agency for
Cancer Incidence in Five Continents, VoTume III. Inter
.
45-50
Research on Cancer (WHO), Lyon, France, 1976, pp.

11

5.2 Data Utilization
The coding of the data collected can determine the usefulness with which
the information can be compared between registries.
Histology
histology.
arise.

There was usage of both ICDO and MOTNAC coding schemes for
The two coding systems are so similar that problems should not

Cancer Site - The cancer registries reported the use of SEER, ICDO, ICDA8
There are differences between these coding
and ICD9 coding schemes.

systems but they are not sufficiently major to cause concern. For
example, the lymphosarcomas are coded differently in ICDO and ICD9, and
sites are more specific in ICD9 as opposed to ICDA8. Conversion code
tables are available which could alleviate some of the problems in dealing
with these different coding systems.

Sta e of Disease - The staging of disease poses more difficulties in
dealing with different coding schemes. 0f the registries that do code
staging information, SEER, TMN and a crude stage classification system are
being used. It is uncertain whether staging information might be used in
further research, but the comparability between registries could only be
satisfied when they use the same coding scheme.

Residence - The coding and specificity of residence differed between the
cancer registries. One registry used the actual name of the residence,
while the others had used various forms of coding systems.

The Michigan

Cancer Foundation Registry was the only one coding to the census tract
level. The remainder used county or district codes. It may be possible
to get exact residence from the original reports, but the coded
information on the registry computers may not be specific enough to
pinpoint cancer risks in small geographic areas.

The utilization of cancer information with each jurisdiction showed that
the registries were supplying information for many purposes. The types of
cancer information disseminated were:

responses to requests; annual

reports; and reports to suppliers of information conducting research,
planning cancer services and control programs, etc.

5.3 Other Compatibility Issues
Multiple primaries - the registries may differ in their registration of
multiple primaries occurring in the same person. If the second primary
cancer is different histologically from the first, the registration of the
new primary is straightforward. However, if the second primary has the
same cell type as the first, the registration process is difficult. The
second primary might be a genuine cancer or a metastasis. The registry
practices in this situation might involve the total reliance upon the
attending physician's judgement or involve a detailed review of each
case.

In general, second primary neoplasms represent less than 5 percent

of the total cases registered.

Even though the number is small, the

practices between registries should be considered.
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Reportable cases - cancer registries may differ in their registration of
cases. The registry may include or exclude in situ carcinoma of certain
sites and other benign conditions. Consistency can be achieved across the
registries by specifically stipulating the cancers of interest. A number
of the registries do not register skin (non melanoma) cancers.
Po ulation covera e - cases of cancer may be missed because certain
institutions (e.g. Veteran's Administration Hospitals) are not covered in
the registration process. The different sources of information used by
the registries (hospital records, pathology reports, death certificates,

physician reports, etc.) also influence the coverage of cancer
registration. The use of several sources will increase overlap of
information on many cancer cases, which: a) assists in the confirmation
of the cancer and patient information; and b) may identify faults in the
registration process (e.g. identify a case from a pathology report when
the hospital record was overlooked).
Dates of diagnosis - the date of diagnosis depends on what information is
available to the registry: date of first symptom; date of biopsy; or date
of first treatment.
It is possible for these dates to differ. These
differences would be minimal and would not cause major problems when
comparing different registries.

5.4 Future Directions
The registries briefly outlined their future directions (details in

Appendix F).

Various developments were described:

increasing and

improving information dissemination; enlarging the registry computer

facilities; placing a greater emphasis on quality control; and improving
the cancer registry system of registration and coding.

5.5 Discussion
Future research studies, which may utilize the cancer registries within
the Great Lakes Basin, will

need to make allowances for the different

types of cancer registration systems, the quality and completeness of the
data in the registry and the utility of using data in different coding
systems.

It appears that the cancer registries within the Great Lakes Basin are in

different stages of evolution.
experience could provide

for research purposes.

Those registries which have more years of

readily available cancer incidence information

Those registries which are younger could only

provide recent or current cases.
There is not sufficient coverage in
years or geography to consider any large scale analysis of cancer

incidence within the Great Lakes region. However, several of the longer
standing registries could begin analysing cancer incidence data within

their own jurisdictions.
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6. Future Developments
The workshop provided the stimulus for the cancer registry representatives
to exchange numerous ideas and to consider the health consequences of toxic
chemicals in the Great Lakes Basin. The discussion allowed the workshop
participants an insight as to how the cancer registry data may be utilized for
further research. A brief sunmary is made of several of the issues discussed.
6.1 Use of Registry Data
If research were to use cancer registry data, it was strongly felt that
support was needed for both the newer and older cancer registries. Such
support will assist the newer registries in their development and provide
added coverage to the very large population residing in the Great Lakes
Basin Area. Continued support would be desirable for the older
registries, in order to pursue the more refined analyses of identifying
cancer hazards in the Great Lakes region and to develop a means whereby
specific residence could be evaluated (e.g. this could involve
considerable effort and resources to refine residence information from
county to city level). In addition, the opportunity presents itself for
the registries to exchange

cancer patient information on residents

identified in other jurisdictions.

6.2 Analysis of Cancer Data
Several cancer registries could begin analysis of cancer incidence data
within their own jurisdictions. These analyses could evaluate if excesses
of cancer incidence are related to specific geographic areas within the
Great Lakes Basin.
Because there are very few registries with over 10 years of incidence
data, it may be beneficial to evaluate cancer mortality patterns within
the Great Lakes Basin. Cancer death information is readily available by
residence, age, sex and site. The analysis of this information since 1950
in concert with the appropriate population census information, would be a
useful tool to identify specific regions with particular cancer risks. It
is conceivable that the analysis of the existing mortality data could be
carried out within a short period of time.

6.3 Extent of Contamination and Health Effects

Before any epidemiological research study could be planned or conducted,
it was felt that a great deal of information was lacking, specifically the
extent of toxic chemical contamination within the Great Lakes Basin and
the presumed health effects as a result of such exposure. If cancer
research were to be conducted utilizing cancer registry data, information
would be needed in order to know more about what contaminants exist, where
the contaminants are, what concentrations exist, what is the level of
human exposure and what human health effects are anticipated. It was felt
that this information should be collected first in order to develop
research hypotheses which have a reasonable chance of being tested.
Detailed information on potable water characteristics in the Great Lakes
Basin would be a useful comparison when the cancer mortality analysis is

completed.
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6.4 Focus on Non-Cancer Outcomes

Because cancer has a long latent period (development of cancer 10-40 years
after exposure) and may not be the only important outcome from toxic
chemical exposure, several non-cancer outcomes were discussed.

Fish Consumption - Because fish are known to contain higher levels of
toxic chemicals, the exposure to humans at a higher level than the
forresearch. Two
ambient environment (air and water) may be useful
Appendix G
Schuman,
(see
Michigan
in
d
conducte
such studies are being
cancer
besides
effects
health
of
range
A
H).
and Humphrey, Appendix
levels
t
Differen
on.
populati
suming
fish-con
could be assessed in a
of consumption could provide a more powerful test to determine the
relationship of a contaminant to human health.

Previous laboratory experiments have dealt with
Animal Studies
exposures to a single toxic chemical. Little is known about what
health effects are related to more than one chemical. It may be
useful to conduct animal feeding studies on concentrates of potable
y
drinking water. In this way the research findings are more closel
water.
g
related to human exposure to numerous chemicals in drinkin

ation
Human Tissues - Various human tissues may provide useful inform
on the exposure to toxic chemicals. Again, this type of information
takes the researcher closer to a human health hazard as opposed to
extrapolating from an exposure level in a lower organism. Several
could
suggestions were made on possible human tissues or fluids which
be readily used:

adipose tissue; breast milk; umbilical cord blood;

or products of birth.

cancer
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6.5 Collection of Risk Factors

information
The cancer registries indicated that little or no risk factor
smoking
ry;
histo
al
was being collected: residence history; occupation
y of

histor
history; female history (parity, menopause, etc.); and family
cigarette
collecting
cancer. Only the Montgomery County Ohio registry was
data on
smoking data and the New York State registry was collecting
collected
data
factor
occupation and smoking. It was felt that the risk
would serve a
would not be very complete or accurate. This information
l in specific
limited purpose and could be collected in greater detai
research studies.
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APPENDIX A

APPROACH TO THE WORKSHOP

AGENDA,

PARTICIPANTS AND WORK GROUPS

A.

Approach to the Workshop

This workshop was sponsored by the IJC Committee on the Assessment of
Human Health Effects of Great Lakes Water Quality on behalf of the Great Lakes
Water Quality Board and the Great Lakes Science Advisory Board and was
considered to be an initial step in assisting in the development of compatible
cancer registries in the Great Lakes Basin. The information thus provided
will be utilized by the International Joint Commission in its advisory role to
the Governments of Canada and the United States.

Under the terms of the 1978 Great Lakes Water Quality Agreement between
Canada and the United States, the emphasis on the control of toxic substances
implies the establishment of an early warning system in which epidemiology
(i.e. the monitoring of human health) would play a significant role.
Compatible cancer registries form an integral part of any proposed
epidemiological study. Such human heath-related approaches are of value in
assessing the ultimate effectiveness of pollution control measures.
Three major objectives were identified for the workshop as:
0

cancer registry characteristics;

0

future developments.

data utilization for research; and

A questionnaire was designed by Dr. Robert F. Spengler to cover these

three objectives in relation to each Great Lakes jurisdiction.

Copies of the

questionnaire were circulated to the workshop invitees requesting completion
of and return to the workshop secretary prior to the workshop. Completed
survey forms can be found in Appendix F.

Workshop participants were representatives of each of the eight Great

Lakes states and the Province of Ontario, responsible for current or planned
cancer registries and representatives of federal government agencies from each
country engaged in cancer-related programs. Resource invitees, Committee
representatives and IJC observers comprised the remainder of the nineteen

workshop attendees.
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B.

Agenda

AGENDA
WORKSHOP ON THE COMPATIBILITY OF GREAT LAKES BASIN CANCER REGISTRIES
9:3OA.M., MARCH 19-20, 1981
CONFERENCE ROOM, INTERNATIONAL JOINT COMMISSION REGIONAL OFFICE
100 OUELLETTE AVENUE, 12TH FLOOR, WINDSOR, ONTARIO
Sponsored by
The IJC Committee on the Assessment of Human Health Effects
of Great Lakes Water Quality
on behalf of the
Great Lakes Water Quality Board
and the

Great Lakes Science Advisory Board

Workshop Chairman:

Dr. Robert F. Spengler,

The Ontario Cancer Treatment and Research Foundation, Toronto

Health Committee Chairman:

Workshop Secretary:

Mr. J.R. Hickman, Health & Welfare Canada, Ottawa

(Dr. G.C. Becking, Acting Chairman)

Dr. Andrew E.P. Watson, IJC Regional Office, Windsor

THURSDAY, March 19, 1981
9:OOA.M.

REGISTRATION

9:3OA.M.

WELCOME AND INTRODUCTIONS

9:4OA.M.

FIRST PLENARY SESSION, PART I.

An Overview of the Activities of the

IJC Committee on the Assessment of Human Health Effects of Great

Lakes Water Quality - Dr. G.C. Becking, Health & Welfare Canada,

10:15A.M.

10:3OA.M.

Ottawa

- C 0 F F E E -

PART II. Water Contamination by Toxic Chemicals: A Challenge to
r,
Cancer Registries in Assessing Population Risks - Dr. R.F. Spengle
The Ontario Cancer Treatment and Research Foundation, Toronto

PART III.

Cancer Mortality and Drinking Water in Selected Canadian

Municipalities - Dr. D. Wigle, gt 51., Health and Welfare Canada,
Ottawa.

PART IV.

Colon Cancer in Watertown, New York - Dr. W.S. Burnett,

New York State Department of Health, Albany

11:3OA.M.

PART V.

The Formation of Workshop Work Groups to address the

Group Chairmen
following three objectives and the selection of Work

and Rapporteurs
Cancer Registry Characteristics
1.
Data Utilization for Research
2.
3.
Future Developments

12:OOP.M.
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Agenda (cont'd)

WORKSHOP WORK GROUPS CONVENED

l:3OP.M.

- C O F F E E

3:00P.M.

COLLECT WORKING NOTES FOR TYPING; BREAK FOR DINNER

5:30P.M.

- OPTIONAL EVENING SESSIONS FOR WORK GROUPS FRIDAY, March 20, 1981

8:00A.M.

REGIONAL OFFICE STAFF - TYPING, COPYING AND DISTRIBUTION OF
MATERIALS

9:OOA.M.

SECOND PLENARY SESSION*
PART I. Report of Work Group on Cancer Registry Characteristics

9:3OA.M.

PART II.

lO:OOA.M.

PART III.

Report of Work Group on Data UtiTization for Research
Report of Work Group on Future DeveTopments

- C O F F E E -

10:3OA.M.
10:45A.M.

PART IV.

Genera] Discussion of Work Group Reports

- L U N C H

12:00P.M.

1:30P.M.

THIRD PLENARY SESSION, PART I. Draft of Workshop
Recommendations and of Workshop Proceedings
- Discussion

2:30P.M.

PART II.

Sumnary Remarks by Workshop Chairman
ADJOURNMENT

3:00P.M.

* N.B. Times shown for Parts I - III incTude 5 minutes each for question

cIarification by

the Chairman
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C.

Participants

WORKSHOP ON THE COMPATIBILITY OF GREAT LAKES BASIN CANCER REGISTRIES
Sponsored by
Great Lakes Science Advisory Board and the Great Lakes Water Quality Board
Committee on the Assessment of Human Health Effects
of Great Lakes Water Quality

Dr. Robert F. Spengler (Workshop Chairman)
Division of Epidemiology and Statistics
The Ontario Cancer Treatment and
Research Foundation
7 Overlea Boulevard
Toronto, Ontario M4H 1A8

Dr. Earl F. Pollock
National Cancer Institute

Dr. Henry Anderson

Landow Building, Room 5-C-O3

Director

7910 Woodmont Avenue
Bethesda, Maryland 20205

Environmental Epidemiology
Wisconsin Department of Health
1 West Wilson Street
Madison, Wisconsin

Dr. Leonard Schuman
Director of Epidemiology
School of Public Health
1360 Mayo Memorial Building
University of Minnesota
Minneapolis, Minnesota 55455

53701

Dr. W.S. Burnett
Assistant Director
Bureau of Cancer Control

State of New York Department of Health

Office of Public Health

Dr. James M. Shuler
Office of Chemical Risk
Indiana State Board of Health

Tower Building, Empire State Plaza
Albany, New York

12237

1330 W. Michigan Street
Room A-412, P.O. Box 1964
Indianapolis, Indiana 46206

Mr. Robert Indian

Division of Epidemiology
Ohio Department of Health
P.0. Box 118
Columbus, Ohio
43216

Mr. John Silins
Chief, Vital Statistics
& Disease Registries Section
Statistics Canada
R.H. Coats Building
Holland & Scott Streets
Tunney's Pasture
Ottawa, Ontario K1A 0T6

Dr. John Isbister
Disease Control Officer

State of Michigan
Department of Public Health
Lansing, Michigan

30035

Dr. Dwight T. Janerich, DDS
Director

Dr. Marie Swanson
Director
Michigan Cancer Foundation
110 East Warren
Detroit, Michigan 48201

Bureau of Cancer Control
State of New York Department of Health
Office of Public Health
Tower Building, Empire State Plaza
Albany, New York

Dr. Katherine Marconi
Division of Chronic Disease Control
Pennsylvania State Department of Health
P.O. Box 90
Harrisburg, Pennsylvania 17120

12237

21

Observers

Participants (cont'd)

Dr. Andrew E.P. Watson (Workshop Secretary) Dr. Peter Boyie

West of Scotiand Cancer Group

Scientist
Internationai Joint Commission

Glasgow, Scotiand

Great Lakes Regionai Office
100 Oueiiette Avenue, 8th Fioor
Windsor, Ontario N9A 6T3

Dr. Joe] Fisher
Environmental Adviser
Internationai Joint Commission

1717 H Street N.w.
Washington, D.C. 20440

Dr. Donaid Wigie

Chief
Non Comnunicabie Disease
Laboratory Center for Disease Controi
LCDC Buiiding, Tunney's Pasture
Hoiiand Avenue
Ottawa, Ontario K1A 0L2

Dr. Joan C. McEwan

Chief

Heaith Studies Services

Speciai Studies & Services Branch
Ontario Ministry of Labor
400 University Avenue

Resource Person

8th Fioor

Toronto, Ontario

Dr. Haroid E.B. Humphrey
Environmentai Epidemioiogist
State of Michigan
Department of Pubiic Heaith

3500 N. Logan Street
Lansing, Michigan 48914
Committee Representation

Dr. George C. Becking, Chief
(Acting Committee Chairman)
Environmentai Toxicoiogy Division

Department of Nationai Heaith & Weifare
Environmentai Heaith Center
Room 118
Ottawa, Ontario K1A 0L2
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D.

Work Groups and Tasks

1.

CANCER REGISTRY CHARACTERISTICS
Participants:

Dr. N.S. Burnett (NY), Dr. H.E.B. Humphrey (MI),
Dr. J. Isbister (MI , *Dr. K. Marconi (PA), and

Dr. J.M. ShuTer (IN

Tasks:

Review

surveyquestions 1 to 2.1

Prepare comparison tabTes

Compare quaTity controT measures
Draft minimum data set
Propose data deveTopments

DATA UTILIZATION FOR RESEARCH
Participants:

Dr. H. Anderson (WI), Dr. P. BoyTe (Observer),

Dr. D.T. Janerich (NY), *Dr. E.F. PoTTock (NCI),

Mr. J. SiTTins (NCIRS) and Dr. M. Swanson (MI)
Tasks:

Review survey questions 2 to 2.8
Assess data usefuiness
Assess quaTity and compTeteness
Assess TeveT of residence
Determine current registry uses
Review registry directions
Address issues of confidentiaiity and access

FUTURE DEVELOPMENTS
Participants:

Mr. R. Indian (0H), Dr. J.C. McEwan (Observer),
Dr. L. Schuman (MN), *Dr. R.F. Spengier (ONT),

and Dr. D. Wigie (LCDC)

Tasks:

*

Review survey question 3 to 3.3
Investigate case exchange between jurisdictions
Propose potentiai studies
ExpTore data sources
Investigate non cancer outcomes
Review current heaith studies in Great Lakes Basin
Determine research priorities

Denotes Chairman of Task Groups
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APPENDIX B

"ACTIVITIES OF THE IJC COMMITTEE ON THE
ASSESSMENT OF HUMAN HEALTH EFFECTS OF
GREAT LAKES WATER QUALITY - AN OVERVIEW",
BY DR. G.C. BECKING, HEALTH AND WELFARE CANADA
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ACTIVITIES OF THE IJC COMMITTEE
ON THE ASSESSMENT OF HUMAN HEALTH
EFFECTS OF GREAT LAKES WATER
QUALITY - AN OVERVIEW
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in order to arrive at an acceptable hazard evaluation. As of November 1980,
exposure data on most chemicals listed in Appendix E were not available. For
that reason only toxicological evaluations were carried out. In summary, of
the 381 chemicals listed in Appendix E, there were insufficient toxicity data
on 292 and only acute toxicity data on another 18 chemicals. 0f the remaining
71 chemicals, 33 are known to cause chronic effects in man (mostly from
exposure to high levels in the workplace) and 38 are known to cause chronic
adverse effects in experimental animals.
Having completed an initial evaluation of toxicities we are faced with the
onerous task of obtaining exposure data. In all probability we will beforced
to use such surrogates of exposure as production and/or use figures, leading
to much less credible hazard evaluations. This is presently an ongoing
activity.

Once the Committee has identified the most hazardous Appendix E chemicals,
I am sure the Public and/or governments will be asking whether health effects
have already occurred. For instance, has exposure to one or more of these
hazardous compounds led to an increased incidence of cancer? Early in 1980
the Committee investigated the types of cancer registries in Ontario and New
York,

in order to ascertain the availability of the health data required to

answer this question. It became evident that the Committee required the
assistance of experts in the area of cancer registries and epidemiology if it

were to provide meaningful advice to the IJC.

to the convening of this Workshop.

Such a conclusion led directly

The Committee will continue to address the problems associated with the
design of epidemiological studies and the data needs for such investigations.
Also, interactions in toxicology, effects of toxic chemicals on high risk
populations, the effects of environmental contaminants on behaviour and the

immune system and the adequacy of present action levels and guidelines will be
addressed.
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APPENDIX C
"WATER CONTAMINATION BY TOXIC CHEMICALS:

A CHALLENGE

TO CANCER REGISTRIES IN ASSESSING POPULATION RISKS",
BY DR. ROBERT F. SPENGLER, THE ONTARIO CANCER TREATMENT
AND RESEARCH FOUNDATION
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WATER CONTAMINATION BY TOXIC CHEMICALS
A CHALLENGE TO CANCER REGISTRIES
IN ASSESSING POPULATION RISKS
It is very difficult to assess the health effects associated with

contaminants in drinking water. Very little information exists linking human
health effects such as cancer with water supply. Emphasis on the control of
toxic substances implies the establishment of an early warning system in which
epidemiology could play a significant role.

a
We know that there are toxic chemicals in the Great Lakes water basin as
from
and
result of industrial discharges, agricultural runoff, urban drainage
in lake
air pollution. We also know that these toxic chemicals are present
that
sediment samples, in the water of the lakes themselves and in the fish
live in the lakes. There is an indication of potential carcinogenic
substances in drinking water. However, what effect they have or what
tely assessed.
long-term effect they have on human health has not been accura
Contaminants and Cancer
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These topics are not meant to be mutually exclusive, but

discussions are made on each.

Methodological Problems
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TABLE 1
SELECTED HEALTH OUTCOMES
T0 ASSESS WATER CONTAMINANTS
Heaith Outcome

Contaminant
mercury (1,2)

Minamata disease

cadmiun (1)

Fanconi's syndrome

PCB (1)

chioracne, gnaii newborns

nitrate (1-3)

methemogiobinemia
chiid deveiopnent, mentai

Tead (4-6)

retardation, chronic
nephropathy

suiphate, magnesium (2)

gastro-intestinai irritation

arsenic (2)

ischaemic disease of the
extremities

sodium (2)

hypernatraemia

excessive fiuoride (1)

skeTetaT changes, biackening,

disfigurement of teeth

Note ( ) indicates bibiiographic reference number, see page 38.
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TABLE 2

CANCERS ASSOCIATED WITH WATER CONTAMINANTS*
Cancer Site

Contaminant

nickei (7)

mouth, intestine

arsenic (7)

em,1amw,m 1Md

beryiiium (7)

breast, uterus, bone

chrysotiie asbestos (8)

ga11 biadder, pancreas,
1ung

THM (trihaionethanes) (9 11)

brain, pancreas, biadder,
rectun

chioroform (11,12)

pancreas, 1iver, biadder,

chiorinated water (11,13)

esophagus, 1iver, 1arge
intestine, rectun, biadder,

1eukemia

intestine, rectun, a11
cancers

kidney

esophagus, 1arynx, 1ung, G. I.

Ohio surface water (11,14)

tract, urinary tract,
lynphosarcona, reticuiosarcana,
a11 cancers

1iver, G.

Mississippi River (11)

I. tract, urinary

tract, a11 cancers

a correiation with cancer;
*Seiected studies have identified

however, a causa]

reiationship has not been proven.

c reference number, see page 38.
Note ( ) indicates bibiiographi
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Obviously, socioeconomic status is related to particular cancer sites and
may also be related to the place of residence and water distribution systems.
Life style elements -- diet, smoking and alcohol -- could have a major
effect on any cancer association, especially for cancers of the pancreas,
lung, stomach and colon.

In the United States, there are marked differences in cancer rates between

blacks and whites, migrant groups and certain religions and in Canada the
situation may be more pronounced.

A person years analysis could be very useful, but implies a means of
following up residents. People do not tend to live in one place all their
lives. Population mobility is a potential problem in cancer studies due to
the long latent periods between exposure and the onset of disease.

Occupation may also play a major role in any cancer excess, especially

when the excess occurs in one sex group.
Issues in Causality

Several issues must be considered when one evaluates the association
between water contaminants and cancer.
Should one consider that water

contaminants have an equal effect on both sexes? If a risk association holds
for both sexes, perhaps this evidence should be given greater weight as to an
environmental exposure. Usually a higher risk in males than females has been
used in the past to infer an occupational association. However, we know that
chloroform causes kidney cancer in male but not in female mice.

Until now, studies have correlated disease rates with concentration

levels. It is important to know that higher risk results from higher
exposure. The causal association would be enhanced further if we knew more
about exposures over time, length of residence and latency periods.

A major problem is the fact that water contaminants can be numerous as
well as unmeasured. Also, the process of water purification can in itself
produce many potentially carcinogenic chemical compounds. To focus on the one
chemical which fits a correlation may be inappropriate.
Lastly, it is obvious that the effects of confounding variables must be
controlled as much as possible.

piscussion
If John Snow in 1885 had had similar concerns, perhaps he would not have

investigated the cholera outbreak in London and not been able to identify the
disease that was associated with drinking water containing fecal contaminants. However, he was able to look at the actual risks on a household
basis and of course, the short incubation period simplified his research.

The point is that we should not be overly pessimistic, but we should be aware
of the many problems and develop ways of dealing with them.

approaches will be discussed.

Several

Cancer Surveillance

Compatible cancer registries within the Great Lakes water basin could
become an integral part of risk assessment. Cancer registries could also help
to assess the effectiveness of pollution control measures. A population based
registry is a collection of every single cancer case diagnosed in its
jurisdiction.

Each person is registered, having his name, date of birth, site

of cancer, cell type of disease, his residence and other information collected
in a uniform fashion. The data undergo rigorous quality control in terms of
coding, checking to make sure that a case is not reported more than once and
identifying every possible case.
Case Control Studies

A cancer registry can be used for numerous purposes. It can be used to
identify cases of a particular disease and a suitable control group. This
sort of case-control study can then use questionnaires in identifying what
previous exposures individuals may have had in the past: certain things in
their diet; certain chemicals they might be exposed to in their work place;
their lifestyle habits in terms of the amount of alcohol they consume; or
whether they are cigarette smokers; and past history on residence, occupation
and potable water sources. A case-control study approach can identify
potential risk factors that are more prevalent amongst the cases than amongst
would be
the control group. The gastro-intestinal or urinary tract cancers
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Abstract

Drinking water quality and mortality data for selected Canadian
municipalities were analyzed with emphasis on asbestos and gastrointestinal
cancers. Using linear regression analysis, gastrointestinal cancer mortality
rates were significantly correlated with asbestos concentration (males,
r=-0.43; females, r=-0.36), fluoridation (females, r=0.21), total organic
carbon (females, r=0.32), trihalomethanes (males, r=0.45) and water hardness
(males, r=-0.34). Mortality rates for individual gastrointestinal cancer
sites were consistently and significantly negatively correlated with asbestos
concentration. Municipalities with high drinking water asbestos concentrations had consistently lower age-standardized total and gastrointestinal
cancer mortality rates compared to low asbestos municipalities matched for
water source and chlorination and fluoridation status. Sherbrooke, a
relatively large municipality with high asbestos concentrations due to
longstanding natural sources and lack of filtration, had lower agestandardized gastrointestinal cancer mortality rates than low asbestos
municipalities matched for water source, chlorination status and population.

Multiple regression analysis between age-standardized cancer mortality rates
and ten demographic and water quality characteristics in 28 cities yielded
negative associations between asbestos and most cancer sites except lung and
lymphatic cancers in females (B=0.32 and 0.38, respectively). However these
associations were not statistically significant. The negative results of this
study may be due to a variety of limitations including relatively low exposure
(compared to occupational groups), population mobility, use of recent rather
than historical water quality data and lack of control for potential
confounding variables including diet.
Introduction

The potential health effects of the contamination of drinking water
supplies by asbestos fibres and chemicals known or suspected to be
carcinogenic have been investigated during recent years (1-11). In view of

the concern raised by the early studies (1,6), the Environmental Health

Directorate of Health and Welfare Canada conducted two national surveys of

municipal drinking water supplies (12,13).

The first of these surveys (12)

was carried out in 1976 1977 in 70 municipalities for which samples were
collected from raw water intake (prior to prechlorination), treated water
(immediately after all forms of treatment) and two public buildings,
respectively, about % mile and 1 mile from the water treatment plant. Samples
were analyzed for total organic carbon and halomethanes. The second survey
(13) was carried out in August and September 1977 in 71 municipalities and,
where possible, samples were collected from raw water, treated water and the
distribution system. These samples were analyzed for asbestos using
transmission electron microscopy with verification by selected area electron
diffraction and energy dispersive X-ray analysis. The two surveys overlapped
each other with only 32 municipalities included in both.

In order to determine if drinking water quality was related to detectable
health effects, a mortality study with emphasis on cancer and asbestos was
undertaken.
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Methods

- .MortaTity data for the period 1966 to 1976 were obtained from the HeaTth
DiViSion of Statistics Canada. The geographic area served by each municipaT
water suppTy was determined (14) and the standard geographic codes used on
VitaT statistics records and corresponding to the defined geographic areas
were identified. The person-years at risk by sex and age (0-4, 5 9, 10-14,
15 19, 20 24, 25-34, 35-44, 45 54, 55-64, 65-69, 70+) for each municipality
(i) Tinear interpoTation of census data for 1966, 1971 and
were estimated by:
1976; (ii) adjustment for municipaT boundary changes. Demographic data for
municipaTities were obtained from Statistics Canada pubTications, (15-24)
microfiche and microfiTm. Data concerning fTuoridation, water source, water

hardness (caTcium pTus magnesium) and fiTtration status were obtained from
pubTications (12,13,25,26).

For certain municipaTities it was necessary to

phone the person in charge of the drinking water treatment pTant to determine
the year in which fTuoridation was introduced.

Age specific mortaTity rates and direct age standardized mortaTity rates
(ASMRs) for the period 1966 to 1976 were caTcuTated using the 1971 Canadian
popuTation as standard. Standard errors of ASMRs were caTcuTated using
n
Chiang's method (27). MuTtipTe regression anaTysis with Teast-wise deTetio
(SPSS,
s
was conducted using the StatisticaT Package for the SociaT Science

version 7.2).

t anaTyses
The demographic and water quaTity variabTes used in the presen
were defined as foTTows:
i

ii

iii
iv
v
vi

vii

water source - 1 = surface, 2 = mixed, 3 = ground;

os in
asbestos concentration - the concentration of chrysotiTe asbestes;
sampT
m water
miTTions of fibres per Titre in distribution syste
yes;
=
2
no,
=
1
fTuoridation
m water sampTes;
totaT organic carbon - mg/L in distribution syste
ug/L in distribution system water sampTes;
trihaTomethanes
sium (mg/L) in
hardness - the concentration of caTcium pTus magne
.
distribution system water sampTes;
geographic area
in
miTe
e
squar
per
ns
perso
popuTation density
served by water suppTy;

viii average famiTy income - 1971 Census;
ix
x

_
asbestos mining (1 = no, 2 = yes);
the popuTation aged 5 or
percent Tess than grade 9 - the percent of
e highest education
oner, not attending schooT fuTT-time whos
9.
achieved was Tess than grade

ResuTts

r QuaTity VariabTes
CorreTation Between Demographic and Wate

een seTected demographic and
The Pearson correTation coefficients betw
cipaTities are presented in TabTe 1.
water quaTity characteristics of the muni
water was SignificantTy correTated
The concentration of asbestos in drinking
education

ng (r=0.59
with trihaTomethanes (r=0.33), asbestos mini
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and Tow

i
T
T
i
T
I

TABLE I

AND NATER QUALITY VARIABLES
PEARSON CORRELATION COEFFICIENTS BETNEEN DEMOGRAPHIC
NATER
SOURCE

ASB
CONC

ASBESTOS CONC.1

-.13

FLUORIDATION
TOTAL ORGANIC CARBONl

-.16

-.20

.20

.03

TRIHALOMETHANES1

.23

HARDNESS1

.17

POPULATION DENSITY
AVG. FAMILY INCOME
ASBESTOS MINING
% < GRADE 9

-.03
.01

.33*

FLUOR

TOC

THM

POP
DENS

.10

.67**

-.10

-.07

.04

-.21 .

.05

.II

-.13

-.05

.17

.23

.22

NA

.39*

NA

-.15

.14

.11

.34*

.06

-.13

.66**

-.11

.02
-.09

.59**

-.29**

.26*

-.15

1 In sampies from distribution systems

Variables are defined in Methods

ASB
MINING

.12

carbon, THM = trihaiomethanes
NA = Not availabie, TOC = tota] organic

Note:

NATER
HARD

AVG
FAM
INC

.02
-.16

.09
.31*

(r=0.26).

As expected, there were strong correlations between low education

.
en tota1 O
and average family income (r=-0.66) and betwe
Carbon and
lc
rgan
.

trihalomethanes (r=0.67)

Mortality Rates Versus Individual Demographic and Water Quality Variables

Pearson correlation coefficients based on linear regression analysis of
selected demographic and water quality variables versus age-standardized
mortality rates (ASMRs) are presented in Table 2. The number of localities
included in the analyses varied due to missing data.

All-cause mortality

rates for males were significantly correlated with low education (r=0.37),
asbestos concentration ( =~0.23) and hardness ( = 0.36). Total cancer
mortality rates were significantly correlated with total organic carbon
(males, r=0.35; females, r=0.36), trihalomethanes (males, r=0.50), water

hardness (males, r= 0.41), average family income (females, r=-0.26), asbestos

mining (males, r=0.37) and low education (males, r=0.40). Gastrointestinal
cancer mortality rates (ICDA 150-159) were significantly correlated with
asbestos concentration (males, r=-0.43; females, r=-0.36), fluoridation

(females, r=0.21), total organic carbon (females, r=0.32), trihalomethanes
(males, r=0.45), water hardness (males, r=-0.34), population density (males,
r=0.24; females, r=0.27), average family income (males, r=-0.34) and low
education (males, r=0.48; females, r=0.27).

c for
Mortality rates for individual gastrointestinal cancer sites specifi
with
ated
each sex were consistently and significantly negatively correl
between water
ation
correl
ve
negati
strong
a
was
There
asbestos concentration.
s (r=0.04).
hardness and stomach cancer for males (r=-0.56) but not female

Quality
Cancer Mortality Rates for Municipalities Grouped by Water
Characteristics

stinal cancer sites for
ASMRs for total cancer and selected gastrointe
stics are presented in Table 3.
municipalities grouped by water quality characteri
concentrations (> 5X106f/L) in
Municipalities with high chrysotile asbestos
on systems had consistently lower
samples taken from drinking water distributi
stinal cancers compared to
ASMRs for all cancers and for selected gastrointe
ions. These mortality rate
municipalities with lower asbestos concentrat
ties for drinking water
ipali
differences persisted after matching munic
regard to chlorination and
with
s
characteristics including source and statu
fluoridation.
Ranked by Asbestos Concentration in
Cancer Mortality Rates for Municipalities
Drinking Water Distribution Systems
testinal cancers for individual
ASMRs for all cancers and selected gastroin
asbestos fibres per litre in
municipalities with more than 2X106 chrysotile r samples are presented in
wate
samples of either raw or distribution sytem
by filtration status and ranked by
Table 4. The municipalities are grouped
systems. There was no apparent
asbestos concentration in distribution
and ASMRs for the selected
correlation between asbestos concentration
lities had less than 1000
It should be noted that the following loca
cancers.

;

TABLE 2
PEARSON CORRELATION COEFFICIENTS BETWEEN SELECTED DEMOGRAPHIC AND WATER QUALITY VARIABLES
AND AGE-STANDARDIZED MORTALITY RATES (AGE 25-69)

FLUOR
(65)

TOC
(31)

THM
(32)

.20
.05

-.23*
-.05

-.01
.00

.17
.20

.24
.03

.36*
.22

.06
-.02

EU

.12
.09

-.12
-.17

.05
.11

.35*
.36*

.50**
.01

-.41*
.29

.15
.16

ELL.

.09
-.02

.29**
-.22*

.26*
.26*

.14
.03

.12
.13

-.28
.45**

.24*
.29*

.05
.20

-.16
-.28*

.29*
.05

ELL

CA. TONGUE, MOUTH
& PHARYNX
46-

CA. ESOPHAGUS

-.13
-.11

-.27*
-.23*

.22*
.27*

.10
.06

.36*
-.O8

-.16
-.10

.31**
.35**

.12
.08

-.38**
-.25*

.27*

.13
.11

.11
.36*

.26
.11

.25
.37*

.35*
.25

ELI

.47**
.35**

.14
-.06

CA. LARGE INTESTINE
INCLUDING RECTUM

M
F

.14
.14

-.26*
-.22*

.32**
.23*

CA. PANCREAS

M

.18
.25*

-.22*
-.41**

.18
.17

GASTROINTESTINAL
CANCER (150-159)

M
F

.10
.12

-.43**
-.36**

.20
.21*

CA. STOMACH

Note:

(1)
(2)
( )
*
**

A58
MINING
(65)

WATER
HARD
(31)

ZU

ALL CANCER

AVG
FAM
INC
(46)

ASB
CONC
(65)

SEX

ALL CAUSES

POP
DENS
(62)

WATER
SOURCE
(56)

F

ASMRs were transformed to Loglo
VariabIes are defined in Methods
Number of locaTIties
p <0.05
p <0.01

-.12
10
.23
.32*

.12
-.23

.45**
.11

% <

GR. 9

(46)

-.05
.10

.20
.05

.37**
.11

-.16
-.26*

.37**
.00

.4o**
.18

.19
.28*

-.27*
-.39**

-.12
-.O3

.36**
.38**

-.22
~.23

.29*
.26*

-.26*
-.20

-.03
.18

.38**
.26**

.12
-.02

.18
.24*

-.07
-.26*

-.03
-.10

.00
.20

.24*
.27*

.34*
.19

-.11
.09

.48**
.27*

.56**
.04

.34*
.24

TABLE 3

ES
AGE STANDARDIZED MORTALITY RATES (AGE 35-69) FOR MUNICIPALITI
ICS
GROUPED BY WATER QUALITY CHARACTERIST

MATCHING VARIABLES

ASBESTOS CONC.
(NO. OF
LOCALITIES)

)
6)

29.5**
35.9

25.6*
30.1

80.5**
92.4

50.8**
57.4

251**
283

200**
216

20.7

7.

29.5**
36.4

25.6*
30.2

80.5**
93.4

50.8**
58.0

251**
286

200**
217

29.8**
38.8

25.8*
32.7

81.2**
98.9

51.1**
61.8

251**
312

200**
231

19.3**
28.6

62.3**
90.1

40.3**
55.6

240**
271

179**
209

24.7

9.

7.

com

I_J

SURFACE WATER SOURCE,
CHLORINATED,
FLUORIDATED

8)1

ALL CANCER
SITES
(ICDA 140-209)
F
M

7.
9.

«.000

CHLORINATED, NOT
FLUORIDATED

4:.
\1

212 !

SURFACE WATER SOURCE,

I_J

SURFACE WATER SOURCE,
CHLORINATED

TOTAL
G.I. CANCER
(ICDA 150 159)
F
M

20.

KO QC

H (8)1
L

NONE

CA. LARGE
INTESTINE
INCL. RECTUM
153 154)
(ICDA
________L
F
M

STOMACH
CANCER
(ICDA 151)
F
M

10.

.8** 21.9**
34.9
4

HI: 5X105f/L; L < 5X106f/L (in distribution system)
* p <0.05
** p <0.01
1
2
3

groups by
statistical significance of difference between ASMRs for high and Tow asbestos
cancer site and sex

Whitehorse, Baie Verte
Asbestos, Sherbrooke, Thetford Mines, Hearst, Kamioops, Vancouver,
Verte
Asbestos, Sherbrooke, Thetford Mines, Hearst, Vancouver, Baie
Kamioops, Whitehorse
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TABLE 4

25-69) FOR LOCALITIES RANKED
AGE-STANDARDIZED MORTALITY RATES (AGE
DISTRIBUTION SYSTEM
HATER
IN
ION
NTRAT
CONCE
BY ASBESTOS

24.1
29.0
18.7
18.4
24.8

)
'Nr- Q'wq

vmmoou:

22.2
20.0
14.7
25.9
16.8
16.5
21.3
22.2
17.9

TOTAL

6. 1. CANCER

(ICDA 150 159)
E
M

72.0
92.8

45.6
53.2
34.5
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199,376
463,219

170
<0.8
2.6
6.4
2.1(4.2)
190
4.6
36
31
142
83
8
4.
2
2

1..

ASBESTOS T
CHICOUTIMI
REGINA
MEDICINE HAT
MONTREAL
THOMPSON
OTTANA
PORTAGE LA PRAIRIE
SELKIRK
TILBURY
LETHBRIDGE
PRINCE ALBERT
SASKATOON
QUEBEC
EDMONTON

D

9,749
56,964
139,479
26,518
1,762,709
19,001
326,956
12,950
9,331
3,582
41,217
28,464
126,449

H

FILTERED

ASBESTOSl
couc
35!

U)

1971
POPULATION

CA. LARGE
INTESTINE
(ICDA 150-159)
F
M

STOMACH
CANCER
(ICDA 151)
F
M

46.6
43.7
41.5
44.0
32.5
35.0
33.0
39.3
37.9
44.7
36.2

UNFILTERED
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#6 in TabTe 1)
3 M11Tions of fibres per Iitre (see Footnote
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- No deaths

N
cod-Hanom
c
O
n
s
mm-a-oommw

________._.

MNN

NATIONAL

N
to
.432

153
123
59
57
15
10

I

LO
0
V

2,397
3,384
92,930
23,723
11,217
514
3,501
30,717
1,011,049
7,748
535,217
108,411
6,122
7,625
2,669

BAIE VERTE +
DISRAELI +
SHERBROOKE
THETFORD MINES T
NHITEHORSE
BEAULAC
HEARST
KAMLOOPS
VANCOUVER
SANDER
HINNIPEG
THUNDER BAY
YELLOWKNIFE
LABRADOR CITY
INUVIK

400
160(280)
73
140#
270(280)
24 T
NA
11
<0
2
0.
2
3
5
O.

+ Ashestos mining in or near Tocality
# Treated water sampTed

A

ALL CANCER
SITES

( ICDA 140-209)
M

E

253
252
171
156
237
131
194
152
149
190
155
158
177
276
173

162
168
141
165
176
190
157
169
173
175
122
139
145
177
139

14.5
23.2
36.7
11.5

21.1
25.1
19.8
14.2

58.0
67.5
104.3
43.8

47.8
39.1
42.2
42.6

11.4
16.1
21.0
30.7
24.9
21.9
35.7
23.9

29.3
13.4
18.0
16.6
20.2
18.0
22.3
27.7

87.5
43.3
57.0
84.7
62.8
70.7
66.5
103.2
32.4

60.1
25.9
36.5
26.6
41.2
41.1
38.1
52.3
125.0

144
157
208
311
263
162
183
157
179
200
191
200
211
266
74

23.3

20.8

60.1

39.9

185

67
111
152
138
117
139
131
146
156
151
343
202
250

149

persons aged 55 or older: 'Thompson, Tilbury, Baie Verte, Disraeli, Beaulac,
Hearst, Gander, Labrador City, Inuvik and Yellowknife. The ASMRs for cancer

for these places should be interpreted cautiously as they are based on small
numbers of persons at risk.

Mortality Rates for Sherbrooke and Comparison Municipalities

Sherbrooke was selected for presentation of detailed cause specific

mortality rates because the asbestos concentration was unusually high
is
(153x106 f/L in distribution system water), the asbestos contamination
to
due
nated
contami
lake
a
from
is
supply
due to natural sources (the water
at
tion
popula
the
ted,
conduc
not
is
natural serpentine deposits), filtration
os
asbest
no
is
there
and
)
92,930
risk is quite large (1971 population was
ooke were compared
mining industry in the immediate region. ASMRs for Sherbr
ns and matched
tratio
concen
os
with those for 7 municipalities with low asbest

size.
for water source (surface), chlorination status and population
were

ison group
Differences between ASMRs for Sherbrooke and the compar
cancer sites examined
all
for
relatively minor and statistically insignificant
both sexes were
in
r
cance
(Table 5). The ASMRs for total gastrointestinal
lower in Sherbrooke than the comparison group.

Multiple Regression Analysis

demographic and water
Multiple regression analysis was conducted with
ables and ASMRs for various cancer
quality characteristics as independent vari
ts presented in Table 6.
sites as dependent variables with the resul
hardness
Significant correlations included:

(i) all-cause mortality:

water

B=0.63; females, B=O.67); (ii) all(males, B=-O.48), low education (males, n (males, B= 0.35), fluoridation
asbestos concentratio
cancer mortality:
ales, B=0.55), trihalomethanes
(males, B=-0.40), total or anic carbon (fem
females, B= 0.43), population
(males, B=O.50), hardness (males, B= 0.52;
n (females, B=0.40); (iii) esophageal
density (males, B=0.38) and low educatio
(iv) stomach cancer: total
cancer: trihalomethanes (males, 8=0.79);
ethanes (females, B= 0.62), hardness
organic carbon (females, 8=0.65), trihalom
e intestine including rectum:
(males, B=-0.70); (v) cancer of the larg
(vi) total gastrointestinal cancer:
population density (females, B=O.40);
, trihalomethanes (males, B=0.50) and
asbestos concentration (males, B=-0.45)
.38); (vii) kidney cancer:
hardness (males, B=-O.45; females, B=-0 cancer: ground water source
_
der
hardness (males, B=0.47); (viii) blad
c
hati
lymp
of
er
es, B=-0.51); (ix) canc
(females, B=0.58), fluoridation (mal
l
tota
:
emia
es, B=0.66); and (x) leuk
tissues: total organic carbon (mal
(males, B=0.94).

halomethanes
organic carbon (males, B=-0.51), tri

lded positive but statistically
Multiple regression analysis yie
of the
asbestos concentration and cancers
insignificant correlations between
).
ely
tiv
(B=0.32 and 0.38, respec
lung and lymphatic tissues in females
the mouth,
vely correlated With cancers of
Although fluoridation was positi
(Table 2),
ed on simple linear regreSSion
esophagus and large intestine bas
s.
ons for these Site

ve correlati
multiple regression yielded negati
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TABLE 5

AGE STANDARDIZED MORTALITY RATES (AGE 35 69)
FOR SHERBROOKE AND COMPARISON LOCALITIES
MALES

SHERBROOKE

FEMALE
COMPARISON
LOCALITIES

SHERBROOKE

COMPARISON
LOCALITIES

ALL CAUSES

1222

1303

569

625

ALL CANCER

285

298

260

223

7.2

9.7

0.6

1.9

6.5

7.4

0.0

1.5

STOMACH

29.6

27.8

8.9

10.7

LARGE INTESTINE
EXCEPT RECTUM

18.5

24.8

28.1

28.7

RECTUM

13.5

11.3

6.6

8.7

PANCREAS

16.5

17.8

5.4

9.0

92.6

96.4

53.8

65.4

94.8

104.2

20.3

18.1

-

59.4

58.0

-

-

19.2

18.7

-

-

11.4

18.0

TONGUE, MOUTH

& PHARYNX
ESOPHAGUS

TOTAL GASTROIN
TESTINAL CANCER
LUNG
BREAST

UTERUS (CERVIX
& CORPUS)

OVARY

-

-

9.5

3.6

1.7

9.1

6.9

0.6

3.9

BRAIN

10.6

10.6

5.4

5.7

LYMPHATIC

13.6

12.0

10.1

9.2

9.3

9.1

6.0

6.0

14.6

12.7

BLADDER

5.9

KIDNEY

PROSTATE

LEUKEMIA

John (N.B.), Chicoutimi, Trois
7 comparison Tocaiities: Moncton, Saint
(Nfid.). Matched for surface water
Rivieres, Kingston, Sudbury, St. John's
(50,000-99,999).
source, chTorination and popuiation size
Note:

y significant at the 0.05 TeveI by
None of differences are statisticaii
l-taiTed T test.
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TABLE 6
WATER QUALITY MORTALITY STUDY: MULTIPLE REGRESSION ANALYSIS, BETA COEFFICIENTS
(LEAST WISE DELETION, 28 CITIES)

M

ALL CAUSES

F

AVG
FAM

.14
.04

.19
.31

.63**
.67**

.52**
.43**

.38*
.30

.09
.07*

.36
.40*

.17
.16

.37*
.17

.23
.21

.42*
.83**

.56**
.39

ASE
CONC

FLUOR

19.9

um

.14
.01

.29
.23

.07
.05

.12
.45

.04
.26

.48**
.31

.05
.04

.35*
.23

.40*
.03

.06
.55**

.50*
.20

.37*
.02

.50**
.04

.02
.19

$495

2.x

POP

WATER
HARD

HATER

2%

m

ALL CANCER

M

CA. TONGUE, MOUTH
& PHARYNX

M
F

-.21
.05

CA. ESOPHAGUS

M

.23
.32

.31
.28

.36
.07

.45
.17

.79**
.25

.03
.01

.29
.05

.32
.06

.12
.03

F

F

CA. STOMACH

M

-.01
.09

.34
.23

.39
.00

.11
.65**

.27
.62

.70**
.13

.15
.13

.06
.26

.06
.27

CA. LARGE INTESTINE
INCLUDING RECTUM

M
F

.16
.18

.38
.20

.17
.08

.06
.10

.22
.23

.29
.35

.24
.40*

.24

.01

.26
.12

CA. PANCREAS

M

F

-.09
.22

.24
.19

.03
.01

.48
.29

.60
.27

.02
.09

.06
.12

.15
.28

.15
.23

CA. DIGESTIVE
SYSTEM {150 1591

M
F

~.22
.07

.45*
.34

.34
.11

.15
.34

.50*
.13

.45**
.38*

.29
.31

.06
.16

.24
.32

M

.23
.23

.14
.32

~.30
.14

.18
.19

.49*
.30

.59**
.09

.35*
.10

.15
.25

.31

CA. LUNG

.01

.14

.12

.06

.27

.26

.22

.05

.35

F

.32*

.17

.04

.48*

.56**

.11

.09

.42*

CA. UTERUS (18071821 F

.30

~.17

-.07

.29

.28

.41*

.40

F

.08

CA. OVARY

.07

.10

.14

.07

.41

.15

.04

M

.11

CA. PROSTATE
CA. KIDNEY

M

.06
.45

.27
.05'

.16
.02

.14
.51

.47*
.01

.02
.11

.41
.04

.06
.06

CA. BLADDER

M

.24
.58*

.38
.07

.51*
.02

.00
.33

.34
.25

.21
.23

.22
.06

.14
.12

.02
.33

M

.14
.42

.02
.38

.34
.12

.66*
.21

.46
.17

.21
.12

.12
.37

.45
.06

.29

CA. LYMPHATIC

LEUKEMIA (204-2071

M

.12
.05

«.21
.04

.12
.09

.51*
.03

.94**
.17

.21
.29

.31
.01

.01
.14

.05
.17

I

CA. BREAST

TISSUES {200 203)

F

F

F

F

F

F

64 *

k
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.20

.01

Discussion

Given the high risk of peritoneal mesothelioma (28) and other gastro-

intestinal cancers (29) in asbestos workers, the negative

findings of the

present study must be interpreted cautiously. If the high risk of such
cancers in asbestos workers is due to asbestos fibres present in swallowed
sputum, then one would expect asbestos fibres in drinking water to increase
the risk of these cancers in exposed populations. There are several possible
explanations for our negative results:
1.

Dose
Up to 75% of asbestos inhaled by rats appeared in the feces within 30 days

(30). Feces from workers occupationally exposed to high levels of asbestos
revealed 4 to 93 x 106 fibres per gram (average = 26 x 106); samples from

unexgosed persons contained 0.0 to 1.7 X 106 fibres per gram (average = 0.4
X 10 ). Assuming that adult males pass an average of about 150 g of feces
per day 32), the highly exposed workers would eliminate an average of about
3.9 X 10 asbestos fibres per day via the gastrointestinal tract. To obtain
a similar exposure from drinking water alone, a person would have to drink 2
litres of water per day containing 2 X 109 fibres per litre. Even residents
of Sherbrooke, with an average of 153 X 106 fibres per litre in samples from
the distribution system, would have more than an order of magnitude less
gastrointestinal exposure than exposed workers.

2.

Physical Characteristics of Asbestos Fibres

Evidence that asbestos fibre diameter and length determines its
carcinogenic potential comes mainly from animal studies involving injection of
fibres into the pleural or peritoneal cavities and from the knowled e that
fibres greater than 3 pm in diameter or 200 pm in length are unlike y to
reach the alveolar regions (33). Fibres less than 1.4 pm in diameter and
greater than 8 pm in length were found to be most carcinogenic with regard
to mesotheliomas following injection into the pleural cavity (28). Cunningham

e: 31. (31) found that only 2% of the asbestos fibres in fecal specimens from
exposed workers were 2 pm or longer. Fibre length distributions were
determined for 14 of the cities in the Canadian survey (13) and the median
lengths in each city were generally between 0.5 and 0.8 um. However, there

were usually at least 5% of fibres longer than 2 pm and 1-2% longer than 5

pm. No information on fibre diameter was obtained in these two studies
(13,31). If the longer fibres (>5 pm) are also the most carcinogenic for
gastrointestinal cancers, then there should be some increased risk of
gastrointestinal cancer in cities with high concentrations of asbestos in
drinking water but the absolute excess risk must have been too small to be
detectable in the present study.
3.

Population Mobility

Polissar (34) estimated that the excess risk
would be underestimated by 45% due to population
level over a 30 year latent period. The present
usual residence at the time of death and no data
mobility.
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of colon cancer incidence
mobility at the municipality
study is based on place of
were available to adjust for

4.

Use of Mortality Data

Percy gt al. (35) studied cancer deaths during 1970-1971 in areas covered

by the Third National Cancer Survey and found that death certificates
correctly identified 93% of cases known to involve cancers of the colon and

rectum and 5% of deaths attributed to colon and rectum cancers were actually

due to other Sites. The corresponding percentages for other gastrointestinal
cancers were: esophagus: 93%, 4%; stomach: 89%, 9%; pancreas: 90%, 11%.

Thus, if Canadian experience is similar to that in the United States, the use

of mortality data should not seriously weaken the present study.
5.

Use of Recent Exposure Data

The present study utilized exposure data from 1977 and mortality data for
the period 1966 to 1976. Since the latent period between first exposure to a
20 years,
carcinogen and death due to cancer in humans is generally more than
the
reflect
data
quality
water
current
if
the present study is only valid
current
s,
asbesto
to
regard
With
.
situation 20 or more years earlier
and Thetford
concentrations in the drinking water of places such as Sherbrooke
years ago
20-30
ion
situat
the
of
tion
Mines probably do provide a valid indica
and
then
t
presen
s
source
because the water supplies are contaminated by
little
is
there
,
though
l,
filtration has never been introduced. In genera
nature and timing of
historical information readily available concerning the
t be very confident
canno
changes in water treatment methods in Canada and we
have been in
would
that results of present surveys are close to what they
earlier years.

6.

Confounding Variables

antial importance in the
Dietary and other factors are probably of subst
data were available to adjust for
etiology of gastrointestinal cancers but no
ors in the municipalities included
differences in the distribution of such fact
ormed for demographic characteristics
in the present study. Adjustment was perf
ably provide an index of dietary
such as income and mother tongue which prob
much preferable.
habits but a more direct measure would be

on analysis were consistent with
Some of the results of multiple regressi
tively strong positive correlation
previous work. For example, the rela
n is well known (36). There was a
between general mortality and low educatio
elation between water hardness and
statistically significant negative corr
for males and -0.40 for females), a _
major cardiovascular diseases (B= 0.42
tive
in Reference 37). A Significant nega
finding reported by others (reviewed
in
rent
appa
gastrointestinal cancer was
correlation between water hardness and
from
rt
repo
A
for male stomach cancer.
both sexes and was particularly strong
ion between water hardness and male
elat
Poland also indicated a negative corr
e of
sources with a relatively small rang
stomach cancer but only four water
ly
tive
pOSi
(38). Use of ground water was
water hardness values were studied
.
les)
fema
tistically significant only in
correlated with bladder cancer (sta
risk of bladder

y increased relative
Howe et al. (39) found a significantl used nonpublic water supplies; however,
cancer among males but not females who associated with increased risk for
ers, wells, etc.) were
all sources (riv
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maies.

use of surface water
We did not observe a positive correiation between
(8).

Kuzma g3 El.
and cancers of the stomach and bTadder as reported by totaT
organic carbon or
and
Significant associations between various cancers

study but there was no sex
trihaiomethanes were observed in the present
correTation between
concordance. Cantor §t_al. (9) observed a positive
water and cancer of the biadder
bromine-containing trihaTomethanes in drinking
ved but were weaker and Tess
in both sexes. Other associations were obser
present study did not reveaT the
consistent than that for bTadder cancer. The
association between
Tatter but both studies indicated a negative
e: 31. (11) reported
trihaTomethanes and femaTe stomach cancer. Hoganroform and cancers of the
chTo
positive associations in both sexes between
iations between chToroform and
assoc
ive
Targe intestine and biadder and negat
associations between
stomach cancer. There were strong positive
and Teukemia among maTes but not
agus
trihaTomethanes and cancer of the esoph
ations of this type of study
femaies in the present study. Given the Timit
to specuTate about the
(ie. ecoiogicai studies), it seems pointiess
s they are consistent (e.g.
significance of identified associations unTes
independent studies.
ai
present in both sexes) and confirmed in sever
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COLON CANCER IN WATERTOWN, NEW YORK
In one of those routine tabulations that Cancer Registries prepare, it was

noted that the colo-rectal cancer incidence rate during the latter part of the

decade of the 1960's among residents of Jefferson County, New York, was
apparently extremely high. The rate was some three times that of some other
counties of the State and more than twice that of each of the three adjacent
counties. However, these colon cancer rates were not age-adjusted and data
from the 1970 Census was then not yet available.

At that time, the Bureau of Cancer Control was interested in embarking
upon an analytic epidemiologic study of colon cancer. We wanted to select
some area of the State where the rates were significantly different from the
State average.
Concurrently, we were in the process of a total evaluation of the entire

son County, it
When we reviewed the known cases of colon cancer in Jeffer
Natertown,
was soon determined that the entire excess was among residents of
tion
popula
ird of the
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we
try
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the
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the
where
y
count
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Count
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t the true
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oped from
devel
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town
Water
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study
residence. And more important for this
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the Village of Watertown located within the Town of Watert
three Sides by the
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In New York State,
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othe areas of the State the
is not unique to Watertown. In fact, in some
the population for the City.
population of a surrounding town far exceeds

rtown, the rest of Jefferson County
The data available for the City of Wate
morbidity and mortality

and the neighboring counties was reviewed both for
rates calculated.
back to 1950 with the appropriate age-adjusted
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,
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Jefferson County is located along the northern frontier of New York,
adjacent to Canada where Lake Ontario flows into the St. Lawrence River. It
has been for many years the county with a declining economic base, but with a
relatively stable population of approximately 85,000-90,000 inhabitants. In
fact, the population has grown less than 10,000 since 1910.

,

mm... ._;JA41K A. m.

New York State Cancer Reporting System. The system had been used to study
several important cancer problems, but had not been used for small geographic
area analyses. The completeness of reporting had been evaluated some years
before and was believed to have changed very little so that published time
trends in cancer for the State were believed to be valid. But the question
arose whether there was sufficiently accurate and precise information in the
system to investigate small area statistics.

years during the entire time period, the rates for Watertown continued to be
markedly elevated.
We then attempted to assess to what extent selected underreporting of
cancer cases in adjacent counties might have created the appearance of an
elevated risk in Jefferson County. We were fortunate to have a medical
student working on this project for the summer. He surveyed all of the
community hospitals of the four country areas, i.e., Jefferson County and the
three adjacent counties of St. Lawrence--along the St. Lawrence River; Lewis
County--a more remote rural county, and Oswego County-~along the shores of
Lake Ontario, in order to ascertain all cases of colo-rectal cancer in a five
year period. Thus, we could determine the completeness of reporting and
determine the accuracy of our collected data. We believed that those patients
referred directly to the Medical Centers such as in Syracuse, had been
adequately reported.
When compared with cases in the State Cancer Registry, it was found that,
although the number of cases from the Registry was considerably greater than
the number of cases found when reviewing the records in the community
hospitals, only about two-thirds of the cases agreed. There was some
underreporting in all of the counties, but two other problems emerged. We had
only recently (i.e., 1966) begun to access multiple primary neoplasms and many
of the cases were being carried in the State Registry under other cancer
sites. We now attempt to secure reporting of all multiple primary neoplasms.
In addition, at that time, a not insignificant proportion of our cases was
first known to us through the Death Certificate. Some of these cases were
subsequently reported routinely, but a case known only through the death
report has the date of death as the index data and the age is the age at
death. The cancer site is that recorded on the death certificate.
Therefore, we initiated a program to obtain additional, more accurate,
information for all cancer deaths that occurred in hospitals to determine the
date of diagnosis, the age at diagnosis and the cancer site as recorded in the
hospital chart.
A general survey of the economy, industry, geography and geology of the
County was carried out. Highlights included the fact that Jefferson County
and the Black River Valley is in an extended period of economic decline.
Contemporary manufacturing consisted of two types:

1.

Production of paper and goods for the paper industry which is

2.

Manufacturing involving production of high value speciality items
such as hydraulic motors and parts for aerospace use and brakes for
railroad cars.

continuing to decline.

Agriculture continues to be important with dairying predominant. Also it
should be pointed out that the county has an unusually large proportion of the
population employed in seasonal service occupations related to recreation in
the Thousand Island Area.
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Watertown is unique among municipalities in the County, for it draws its
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APPENDIX F
CANCER REGISTRY SURVEY,
COMPLETED QUESTIONNAIRES BY

THE GREAT LAKES BASIN CANCER REGISTRIES
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_
National Cancer

Statistics Canada

:fih8
legistry Name;§§§§§§f f_§fzz

Date: Feb. 16, 1981

CANCER REGISTRY SURVEY
GREAT LAKES BASIN
Please provide short answers to the questions that follow.
If a question or item does not apply, please indicate by 3 'N/A'.

REGISTRY CHARACTERISTICS
1.1

1.2

Describe the current stage of registry development or operation
(when did it start):
started on January 1, 1969
Operational

eristics:
Describe the population coverage, size and charact
Total Canadian Population

tion techniques:
List the registry data sources and collec

N/A

YEAR
STARTED

CURRENT
YEAR

p), risk factors
Death clearance (survivorshi

Describe any future plans:

1.4

COLLECTION
METHOD

MW

DATA
SOURCE

HUME?

1.3

mm
MN

1.0

abstractors,
l and their duties, (clerks,
List the registry personne
).
etc.
rs,
statisticians, programme

Duties

No.

Job Title

1
___

Statistician
~____._._____

1 5

\ | I \'

f

Project manager

coding, publication

Clerical
Technical Support

_____.______.__._

computer programming

M

M

_________,_._..._.- -

,

plans.
Describe any future

human resources.
None with respect to

;

4
2

15

How is the registry directed and funded?

Registry Name:

c° s 1tat1°

NCIRS

pr°V1ded by N3t1°nal

Cancer Institute, Committee of DirECtors of Cancer Registries.

Funding-Federal

Government, Statistics Canada.
1.6

Describe how the data for the cancer registry is:

COLLECTED:

Either in codified machine readable form or reporting form -

depending on source.

CODED:

Diagnosis by trained medical coders; other by trained clerical persons.

COEPuter

PROCESSED:

VERIFIED (EDITED):

Computer checks for valid codes and correlation among specifia

fields.

VALIDATED:

In case of inconsistencies reference is made to reporting

document or reporting organization.

STORED:

1.7

magnetic Lane

:
Describe the follow up techniques that are used by the registry

___.._...._

:esgective Brovincial registries are queried, as required.

1.8

Describe the quality control techniques used by the registry:
verification at time of keying

1.9

Provide estimates for the follouing:
2 6

(use the
__~JK of registry cases are identified by death certificates

number of death certificates only and the number of deaths that

by
were later investigated for cancer site confirmation; divide
year).
same
total incidence cases for the
90'0

Z of registry cases have their diagnoses confirmed by histology
(exclude non-melanoma skin tumours).

A8176§Wcases of newly diagnosed cancer for
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1977

(year)

-

Registry Name:

-3DATA UTILIZATION

Are the following data elements used in the registry?

Registry

N u

0,.

P - Planned).

NumberOIODIOOOOIIUOtIIUOCOIOOOUI'DDIIO

Case Number (for multiple primary sites).......::::::::::::::::..
Last name..........................................

..

First given name............................
.'............
Second given name...........................:::::::::::::::::::..

Maiden name..................................
Street address...............................:::......-.9......0'

city/cm/counzy................................ZIII""ZI'
"""

State/Province......................................
.::...::::...
Zip/Postal code.....................................:..:......:::
Date

Of birthooooooouulcer-ocean..-uncut-octooootoeouooocoo-coco
.

Age at diagnosis.................................................
Race/Nationality.....c..oo......o...................
..-..-.......

Marital status..............................................
.....
.............
Sex.................................................

Date of initial diagnosis........................................
Primary site.....................................................
.............
Histology..........................;................
Method of diagnostic confirmation................................
Paired organ involvement.........................................

....
Size of tumour.........;.....................................
Regional node involvement........................................
Stage at diagnosis...............................................
Date of first treatment..........................................
...........
First course of treatment..............;.............

..u
Date of first recurrence................................,.....
Subsequent treatment(s).......................,..................
.......r..
Date of last contact/death.............................
Status...........................................

.............
...

w v w
m
vagvelv w w w w'v w v m-v w w w w w m w m w w'vlv

(Y = Yes,

é 2:22: 2 2:2:652 z<:yz:zQ§)z'z =:::§§2

2.1

m «:4 a a a x K:< §£Z § § 3 §£§'<E§ED (3§E>¢G§E§E§E§"¢ED

2.0

NCLRS

Other (Please specify) 1
risk factors

2.2

and dates of usage (e.g. SNOP
Please indicate the coding directory used
1972-1978, ICD9 1979+).
BISTOLocy;

CANCER SITE;

1979+ ICD-O Morphology

ICDA S 1969-1978.

STAGE or DISEASE:

RESIDENCE:

2.3

1979
ICD9 1979+ ICD O Topography

N-A.

Standard Geographic Code

conditions are registered;
cancers or non-malignant
Describe how and what skin

Skin cancers

1 for each type applicable.

NCIRS does not include non

situ"
include those considered "in
malignant coditions but does
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,4444e_____________

i-l-lllllIIIIIIIII
-III'IIIIIIIIIIIIIIIIIIIIIIll-ll

'4
1.h

Registry Name:

NCIRS

Describe has cancer death information is used
in the registry:
Ascertainment of additionainew primary sites in provincial registrie

s.

2.5

What census data is readily available to you? (years,
1eVels of residence,
race, sex, etc.):
All published or unpublished data.

2.6

To what degree is the registry data computerized? (years, files, plans, etc.)

All data since 1969 is computerized

2.7

'

List the ways in which the registry data was used in 1980. (reports,
requests, studies, etc.):
1979 annual report

2.8

Describe your present computing abilities to analyze and process registry
data:

comma EQUIHENT:

COMPUTER PERSONNEL:

AMDAHL 470/V6 II under msz'rso

1 person directly responsible for processing

If fee for service, describe arrangements:

Describe any future plans:

"one
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internal bUdSEting

.I-II-----------I-I---IIIIIIIII-I-I-l-I-I-I-I-I-l-I.
'5-

NCIRS
_

-

QEGISTRY DEVELOPMENTS

3.1

Are any of the following items collected for the registry?

(Y

Residence

3

Yes

N

= No

P -- Planned)

history..."no....n.................ua.uon...onu.
hiStorIyCUI

OIDCDIDCOO...It.DOD-c.00DlIOIIOIUOIDIIO

Y
Y

Smoking history.............................................
.. Y
Female history (parity, menopause, etc.)...................... Y

Fanny hismfy of cancer............;......................... 1

zzzz®

3.0

Registry Name:

Other (please specify)

If yes to any of the above, please describe how the data is coded:

N/A

3.2

Please describe any future developments:

At the Preseni deval°pmental

work is going on in the area of death clearance.

generation of crude survivorship rates.

This would permit the

Also preliminary work is going

on to collect data on risk factors.

3.3

1

Are there any other comments that you may haV62= _fifhgg§3_fhfc§3£.gfi£___

Cancer Incidence Reporting System is sometimes referred to as a registry,

its primary purpose is to generate statistics about the incidence of nesL

primary sites.

T::l..l|
_____ _____
________________
________________________________
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Michigan Cancer Incidence Reporting System

Registry Name:

(CIRS)

Date:

2/13/81.

CANCER REGISTRY SURVEY
GREAT LAKES BASIN

Please provide short answers to the questions that follow.
If a question or item does not apply, please indicate by a 'N/A'.

REGISTRY CHARACTERISTICS
1.1

n
Describe the current stage of registry development or operatio
(when did it start):

n
The registry is in the second stage of a pilot operatio

which began October 1, 1980.

1.2

s:
Describe the population coverage, size and characteristic

The pilot is in

five hospitals and it is proposed that the Register will ultimately be statewide,

covering Michigan's 9.2 million population.
techniques:
List the registry data sources and collection

Path. Labs

VOLUME
PER YEAR

CURRENT
YEAR

Describe any future plans:
process refined,

1,600
.

COLLECTION
METHOD

mg

DATA
SOURCE

\HIIFEE
\Hlll

1.3

HlH

- - -

__
. .
._

-

-

When piloting has been completed and thegg

is proposed to extend the Register to cover all tigaue

pathology laboratories in the state.

1.4

duties,
List the registry personnel and their
statisticians, programmers, etc.).

1
-

Cancer Control Consultant

Describe any

future plans:

(clerks, abstractors,

22215.3;

M

No.

HHH

1.0

Initiate participation, receive reports

and code.

When operational at a significant level, ADP will

will be initiated and regular statistical output published.
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Michigan Cancer Incidence

.2.

1.5

How is the

Registry Name;

registry directEd and funded?

IQ; will be state funded

Reporting System

(CIRS)

and directed

by an epidemiologist.

1.6

Describe how the data for the cancer registry isPathologists submit a report form for each case of cancer seen.

COLLECTED:

c0933:

.
According to International classification of diagnoses for oncology

Greater municipality codes are assigned for location.

PROCESSED:

Manually

VERIFIED (EDITED);

from paper file at present.

Not done during pilot

VALIDATED;

Not done during pilot.

STORED:

Paper file presently.

To be automated.

1.7

registry:
niques that are used by the
Describe the follow-up tech

1.8

Describe the quality

the registry:
controltechniques used by

None

Cancer contra;

rts against individual
ally check receipts of repo
consultant will periodic

pathologist's log.

1.9

for the following:
Provide estimates

N/A

100

402

the
th certificates (use
are identified by dea
desths that
of
% of registry cases
ber
num
the
tificates only and
by
number of death cer
confirmation; divide
ted for cancer site
iga
est
inv
er
lat
were
r).
yea
e
sam
es for the
total incidence cas
confirmed by histology
have their diagnoses
Z of registry cases
n tumours).
ma ski
(exclude non melano
reported

cancer for __;2§Q___(yelr)
cases of newly aasguasuc
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(3 month period)

Michigan Cancer Incidence Reporting
System

DATA UTILIZATION

Are the following data elements used in the registry?

Last

First

oeee
u.-noon-c-aeou-ceu-an
n8mEoo-o-u.uooeoc-oeo-one-eneeooooo
uolneoee0.0000000!
nooeel
o.oeeu
ou
oeuohO
none-o
melee.
giVEH

......................
Second given name..........................
......................
......
......
......
......
......
name..
Maiden
Street

address-eloq-.-gen-enoeeoeeeo-oe-oo

ne-gaoooooenoeon-no-eoo

City/town/caunty...................................
oeoo-e-ooo-o
State/PIOVinceoteoIo-otenet-an

..........
....

ouoeee-eovn-I
eueeaooaoo

.......
Zip/Postal code......................................

.....

...........................
Date of birth.........................
......................
......
......
......
......
sis...
diagno
Age at

Rece/Nationality..........................

.............
..........

.....
......................
Marital status........................
.............
.......
.....
.....
.....
.....
.....
.....
Sex............
.........................
Date of initial diagnosis...............
...........................
.....
.....
...t.
.....
.....
site.
y
Primar
.............
.................
Histology..........................

........................
Method of diagnostic confirmation........
............

....................
Paired organ involvement.........
....
............................
.....
.....
.....
Size of tumour....
...........

...............
Regional node involvement..............
..........................
Stage at diagnosis.....................
................

....................
Date of first treatment......
....
..............................
First course of treatment......
...............................
.....
.....
rence
recur
first
of
Date
..............

...............
Subsequent treatment(s).............
...........................
Date of last contact/death............
.............
.......
Stetue........................

Other (Please specifybt

2.2

...............

(e.g. SNOP
ctory used and dates of usage
Please indicate the coding dire
l972-l978, ICD9 1979+).
HISTOLOGY:

I

C

D

O

CANCER SITE:

I

C

D

0

Not coded or reported

STAGE OF DISEASE:

RESIDENCE;

2.3

onm 'um mwm m

nnoun....uuu..u..

...................
Case Number (for multiple primnry sites).....;

z 2;:22 z 2(Egzzz z 212 z 24E§z z 22:2

n.'u.
Registry Number....u.nun.u...

mwm mmwm
vwm m'a mmm wwwmww

P - Planned).

0,.

A

N -

)

(Y - Yes,

C

2.1

~<~<<~<><~<~<GXWW<W

2.0

(CIRS)

legietry um:

-3-

ion Codes
Michigan County and Divil Divis

Describe how and what

conditions etc registered:
skin cancers or non-malignant

All skin cancers are reported.

omaa and
Liver and thyroid adenomas, hepat

menningiomas are reported.
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Michigan Caner Incidence Reporting System

(CIRS)

Registry Name:

2.h

D escribe

ahow cancer death information is used in the regiItty-

Death

records will be matched against register records.

2.5

What
race, census
sex, Etc
data): is read ily available to you? (years, levell of residence,

2.6

To what degree is the registry data computerized? (years, files, plans, etc.)
It is proposed that all data will be computerized when fully operational.

2.7

in 1980. (reports,
List the ways in which the registry data was used

requests, studies, etc.):

,

_.n. ...-..._...Wm .____

Wa n- n.

2.8

N/A

-.,... ......i.(...,...».e. .

..mm....,_.._. v. ....--. n. ....,..

.....

and process registry
uting abilities to analyze
Describe your present comp
data:
OSIRIS and MIDAS
University or Mithigan Amdahl;
COMPUTER EQUIPMENT:

COMPUTER PERSONNEL:

h Statistics.
Staffed Office of Vital and Healt

M...»._. .

xibe arrangements:
If fee for service, desc
_m--.M
whim... m . »_~A.,-v_

luw .g

plans:
Describe any future

444444

w

_

__________________-_--___

-__

________

_____

Michigan Cancer Incidence Reporting System

Registry Home:

'5'

__

-

REGISTRY DEVELOPMENTS

3.1

Are any of the following items collected for the registry?
P - Planned)
N - No
(Y - Yes
hi'tOUIOO QOOCIOIUO IDIIIQCID

UIDIODDOI DOQOIDDCC IIOOOC

Occupational

o
o-tonc
Smoking historyooonooo-o-coo-ooooootuilscooter-oooooooo

Y

1

Y

Y
Female history (parity, menopause, etc .)......................

®
Family history of csncer...................................... 1

M'GM'UV

3.0

(CIRS)

Other (please specify)

how the data is coded:
If yes to any of the above, please describe

3.2

Please describe any future developments:

The CIRS is designed so that data

doing tissue pathology in Michigan.
are collected from all laboratories

It is

ge
expanded to provide statewide covera
expected that this register will be
st degree possible in order to assure
with reporting simplified to the greate
completeness.

3.3

you may have 1:
Are there any other consents that

W

dity
tool in order to identify cancer morbi
CIRS is designed as an epidemiologic
organ involved and cell type.
by age, sex, race, geographic area,
trends and clustering.
over time, permit observation for

76

It will,

.-

f
Michigan Cancer
Foundation Registry
Registry Name:

(MgEB)

2([018]

Date:

CANCER REGISTRY SURVEY
GREAT LAKES BASIN
Please provide short answers to the questions that follow

If a question or item does not apply, please indicate by A 'N/A'
REGISTRY CHARACTERISTICS
operation _
Describe
start): stage of re 8 ist ry d evelopment or
it current
(when did the

1.1

registry sjngg l969.

Describe the population coverage, size and characteristics:

1.2

Population

s; approximately
includes residents of Wayne1 Oakland, and Macomb countie

Large numbers of members
4.1 million persons of which about 20% are black.
ra c immigran s.
recen
0
er
num
arge
y
ar
u
partic
;
of many ethnic groups
'
ues:
techniq
ion
collect
and
List the registry data sources

1.3

CURRENT
YEAR

YEAR
STARTED

DATA
SOURCE

COLLECTION
METHOD

VOLUME
PER YEAR

Hospital

l969

198l

25,400

Abstracting by Registry Staff

Ph sician

l972

__l98l

65,000

Mailed Requests

Facilities

l973

l98l

_§;ggg__

Abstracting_by Registry Staff

Death Certificates

l972

l98l

30,000

Computer_lape

l978

l981

Varies

Interviews with cases and
controls'as appropriate for
ongoing studies

Radiation TFErapy

Research

Describe any future plans:

1.4

abstractors,
l and their duties, (clerks,
List the registry personne

).
statisticians, programmers, etc.

_ __

JL_

Registry
Resoonsible for research and
operation
Research
emiologistZBiostatistician
r

D ~

_l__

Epid

al unit
Administration of each function

Managers
er '

27

Abstractors

ll

Technicians

7?

C erks

and personnel
Daily ooerationofunits

r

J;_

lity control
Data abstracting and qua

7

Codin

of Data

and
sing Batches
Filing, Microfilming, proces

Processin

1&anm

ii

1.0

'03

E

.
.
rations,
ope
er
put
com
and
ign
deS

Systems Analysts
and Computer

System

Interviewers
Administrative Asst.

ch projects
Interviewing for resear
interface
es;
lys
ana
Budget and cost
chasing and
pur
,
nel
son
per
MCF
h
wit
accounting offices.

research support

Programmers

77

How is the registry directed and funded?

1.5

staff and is research oriented.

MCFR

Registry Name:

2.

It is directed b

In: administrating

Ninety-five percent of its funds are from the

are from contracts with hospitals.
National Cancer Institute (U.S.) and five percent
1.6

Describe how the data for the cancer registry is:

COLLECTED:

to physicians.
Abstracting by Registry staff and mailing

Death

of Vital Statistics on computer
certificates are obtained from the Michigan Office

tape and microfilm

coorn:

data, using NCI-SEER and 100 0
Abstractors and technicians code the

specifications

PRoczssED;

Manual and computer

VERIFIED (EDITED) = W

VALIDATED:

_§gmpu1g£_gn1Jminu§l~[eV1ew.

Quality control re-abstracting

annu§]]¥ of a sample of cases.

STORED:

1.7

Computer tape and disk.

Microfiche

es that are used by the registry:
Describe the follow-up techniqu

Actjye annua]

natientsmuecessau W
W a r m 'm nhvsirians' also to
§jnggting_§n
hospital and radiation4thgrnny_§h
data 333 also obtained fhrnuuh

_from

Wifirates

techniques used by the registry:
Describe the quality control

1.8

_____.._.

qmguter edits

Re-abstractinu

wing:
Provide estimates for the follo
.4

1.9

.gug.g

90

(use the
tified by death certificates
Z of registry cases are iden
the:
hs
deet
of
er
numb
the
only and
number of death certificates
irmation; divide by
conf
site
er
canc
for
ated
were later investig
same year).
total incidence cases for the

ology
r diagnoses confirmed by hist
1 of registry cases have thei
.
urs)
tumo
(exclude non-melanoma skin

cancer for
|§,Z]z cases of newly diagnosed

78

1929

(year)

-

3'
DATA UTILIZATION
Are the

following data elements used in the registry?

(Y 8 Yes,

Registry

N - No,.

P - Planned).

tuber-onee-oeeoeen-aooooonoise-nI-oeeooenesue-oeunooto

Case Number (for multiple primary sites)........................:
Last

Flrst

narfEOOOIonlotll.OOOOIOOCOQIIOIOIInII'AOttoullunloeo
lOOOOIO
o

Elven

name-no.ueeo'eoutaooololoeloaoeoeeaoolllooleoeaneolou

Second given name................................................
Maiden name......................................................
Street address...................................................

...........
City/tOWn/county......................................
state/Province..................................................
Zip/Postal code..................................................

Date of birth....................................................
Age at diagnosis..........L......................................

.............
Race/Nationality.......t............................

.....
....
Marital status..........................................
............
.
....
........
........
........
........
........
Sex.....
.........
Date of initial diagnosis...............................
...............
Primary site......................................
.............
...
Histology........................................
.........
.......
.......
.......
ation..
Method of diagnostic confirm
......................
Paired organ involvement...................
....
.......................
Size of tumour........................
.........
......
......
......
......
......
ement.
Regional node involv

............
Stage at diagnosis...........................

........

...........................
Date of first treatment...............
........................
.....
.....
.....
First course of treatment.
...............................
Date of first recurrence..........

........................
Subsequent treatment(s)..................
......................
.....
.....
.....
Date of last contact/death..
.............
.......
.....
..........
Status........................
Type ofsurgery, chemotherap
try;
Indus
on,
pati
Occu
fy):
Other (Please speci

'U U'U U'V'U'd
U'U'd'd'U'U'U UW U U U U'UW'U U V'U'UM'U

2.1

;

MCFR

L< zzzézzzzzzzzzzzzzzzzzzzzzz:zz

2.0

Registry Name:

therapy; census tract;
and radiotherapy; previous

2.2

(e.g. SNOP
ctory used and dates of usage
Please indicate the coding dire
1972-1978, ICD9 1979+).

HISTOLOGY:

CANCER sma:

ICD-O

ICU-0

STAGE or DISEASE: W
RESIDENCE:

2.3

R manual
tract directories and SEE
U.S. Census Bureau census

Describe how and what

istered:
nant conditions are reg
skincancers or non-malig

None

79

2.h

Describe how cancer death information is used in the registry:

v

-

2.5

i a e occu a ion.

of residence,
What census data is readily available to you? (years, levels tract, municensus
race. sex, etc.): Data for each decenniai census by
ion, etc.
andby race. sexl age, housing, income, educat

cipaiity. county

2.6

MCFR

Registry Home:

'4'

erized? (years, files, plans. etc.)
To what degree is the registry data comput
are on tape; written description
A11 data are computerized - master fiies

microfiche
(abstract) upon which codes are based is on

2.7

date was used in 1980. (reports,
List the ways in which the registry
ti]IQ h953j3315; neglmsts in: hgspj
ts
Bgngn
:
etc.)
requests, studies,

and other heaith agenuaLi spning;
specific data frgm h05pitais; cancer controi

n

in

r s

r

-d

'

r'

epidemiologig research; matching and
coiiected data and case seiection for
a suspected excess cancer rate was inanaiysis of industry iistinq where
heaith and medical students.
vestigated; teaching of pubiic

2.8

ess registry
g abilities to analyze and proc
Describe your present computin
data:
§enten__
- utiiizinq a universityroomputg:_
COMPUTER EQUIPMENT: Amdahi V605
red.
and biiied monthiy for costs incur

COMPUTBR PERSONNEL:

10 persons

_nrggrnmmer5,
1 manager, 3 SYStemS4an§l¥§I§ _

2 data entry technicians

arrangements:
If fee for service, describe

Describe any future plans:

39 :9 reduce
Lease of Texas Instruments 229-

rity.
ciency and provide improved secu
costs, improve controi and effi

80

Registry Name:
REGISTRY DEVELOMNTS

Are any of the following item collected for the registry?
(Y ' Yes
N - No
P I Planned)
Residence history-coco-one.locate-0000......

Y

Occupational history........................nu u nu u Y

Smoking history.............................::::.:.::nnn n Y
Female history (parity, menopause,
1

Family history of cancer...................................... Y ®

d

3.1

'd'd'v'

3.0

MCER

Other (please specify)

If yes to any of the above, please describe how the data is coded:

3.2

Please describe any future developments:

W W
and imprOVe efficiency

3.3

you may have?:
Are there any other comments that

York State
Registry Namezuew
_______________
Date: 2420481

.

CANCER REGISTRY SURVEY
GREAT LAKES BASIN

H-

P lease provide short answers to the questions that follow.
1 a question or item does not apply, please indicate by a 'N/A .
1.0

REGISTRY CHARACTERISTICS

1.1

Describe the current stage of registry'development or operation
(when did

Cancer reporting for New York State,

it start):

exclusive of New

1950.
York City, started in 1940; active data files now exist from

Cancer re

with relatively complete data
porting7£rom New York City was initiated in 1973

1.2

Describe the population coverage, size and characteristics:

The population

inhabitants (Census 1980
covered includes the entire State with 17,507,541
1.3x other
The racial groups are 86.8t white, 11.9 black and
preliminary).

(1970 census).

1.3

List the registry data sources and collection techniques:
YEAR
STARTED

DATA
SOURCE

Hospitals

.

VOLUME
PER YEAR

CURRENT
YEAR

Report form

72,007

1979**

1940 (1950)

COLLECTION
METHOD

Computer tape

1979

8,045

Laboratories 1940 (1950)

1979

21,107

Copies of Lab.

(1950)

1978

41,175

Computer tape

1978

"

Deaths

1940

.__

-

reports

_

also available.
*Data available from 1950. * Cases received through September 1980
ggmgggggnggs, timeliness of
anrjnug :9 assg
future plans:
Describe any

reporting, and quality of information.

1.4

List the registry personnel and their duties, (clerks, abstractors,
statisticians, programmers, etc.).

52;
1

____
1
___

Job Title

Duties

Medical Director

(23:: time)
Administrative
Director (Part'time)

Responsible for overall direction and

meintenance.
Responsible for securing additional funding
and handling general administrative functions.
Responsible for day-to day management.

Supervisor

1

visor
___AsS. t_- our...

M W and

_1_

Medical Coding &

Check "possible matches" and resolve multiple

_1_

Programmer

Maintain data baSe, produce routine output

TYPiSt

Enters data from Lab. reports; correspondence

2~

Field Investigators

Maintain constant liaison with reporting

Describe any

future plans:

.1.
_;__
3

_$_.

__

Publish annual reports.

specific coding.
Code simple items of hospital, sex,residence at:
Mail Clerks
Medical Coding Clerks Code site and histology
Processing Clerks

primaries.

process special reports.

with hospitals.

Code selected sites of cancer for

l

Coding Clerk

1

Statistician (Part .
time consultant)

7

institutions.

occupation

82

and industry.

Statistical consultation.

.

L

I
-2-

(h

,4

1.5

H0

is the registry directed and funded? .

Registry Name:

.
New York state

New York State

Describe how the data for the cancer recistry iseOLLECTED:

Hospitals submit reporting forms monthly.

mitted quarterly;
files

Computer tapes are sub-

Laboratory reports are submitted monthly.

computerized death

(subset of Vital Stat Files) prepared annually.

CODED:

sex, country of
Report from each day coded for hospital of report,

birth, etc.

sorted Soundex.
Monthly batch for both cards and laboratory reports

yRocgssgn;

Site and histology coded by medical coding clerks.

VERIFIED

(EDITED):

s the entire card
Then another medical coding clerk review

coding.
checking especially the site and histology

After monthly batch is key-

incorrect and missing information; then
punched, computer edits are run to detect

M batch is run against Registry.

STORED:

filed Soundex with cards and
Reports received during any year are

laboratory reports filed separated.

':.7

are used by the registry:
Describe the follow-up techniques that

_ug_§g§;§E£;;§

follow up.

iques used by the registry:
Describe the quality control techn

Laggmplg§§_in:___

prior to adding data
rting hospitals; computer edits
fgzmgtion ggeried back to repo
matching to
These have included internal
as necessary,
qpbseguent ad hoc edits
esses, etc.
lists of unknown ages, addr
eliminate more duplicates;
Provide estimates

23-0

for the following:

by death certificates (use the
z of registry cases are identified
the number of deaths that
of death certificates only and

number

divide by
cancer site confirmation;
were late: investigated for
1978.
for
same year)
total incidenCe cases for the

diagnoses confirmed by histology
_§§;i_3t at reydstry cases have their
for 1973-1977.
ch:_e;; nan-uclanema skin tumours)

(yea:
d cancer for _1918
6§L§ g__chnzs of newly diagnose
a insitu of cervix uteri
y diagnosed carcinom
2,309 cases of newl
1,000 (est) other cases

83

'3

DATA UTILIZATION
Are the following data elements used in the registry?
(Y = Yes,
N - o,
P I Planned).
'qu v'..-.
v
.., . _.be-.............................................
.....
J'sber (for multiple primary sites).........................

Y,

K

P

5: name........................................................

Q

n

P

.'
Y

K
GS

P
P

CB

z

P

Y
35

State/Province......................................
.............

(:5

Date of birth....................................................

CE

Pt

Cb

Zip/Postal code..................................................

Age at diagnosis...........,...................... ..............
\1

.a

Sex.................................................
.............

Date of initial diagnosis........................................
V?:imary sitex...............................................
.....
Histology...........................................
.......;.....

Xethod of diagnostic confirmation................................
Paired organ involvement.........................................

Size of tumour...............................................
....

Regional node involvement........................................

Stage at diagnosis...............................................
Date of first treatment..........................................
First course of treatment........................................
Date of first recurrence.........................................
Subsequent treatment(s)..........................................
Date of last contact/death.......................................

Y

CD

I
\

ii:y/to=n/county............................}..........
..........

f
.1

Status...................,..............r...........
.............
£Collected_xnu;Juzt_snd§§-*'Hicroscopio confirmation

P*
P
P

P)?

m m'd m mlv m w'vcv : w mrw w m w m m

Leiden name.........;............................................
Street address...................................................

z2 z z z . z

First given name...........................L...................:.
Second given name...........,....................................

?

s

;ezgg ;@2:::zzz z

=

\

a;

2.1

x mu< m «u<(:y<.<.<n<G§E§

2;0

New York State

Registry Name:

Other (Please Specify); Country of birth, cigarette smoker, social security number,
industry and occupation, date of birth.

2.2

Please indicate the coding directory used and dates of usage (e.g. SNOP

l972-1978, 1CD9 1979+).

HISTOLOGY:

Manual of Tumor Nomenclature & Coding 1968 (First 3 digits)

CANCER SITE:

ICD 9th

STAGE OF DISEASE:

RESIDENCE;

Insitu, localized, Regional,

getastatic

Registration Districts for Vital Records that conform to oolitical

subdivisions of cities, towns and villages.

'earribe how and what

skin cancers or non-malignant conditions are registered:

. Malignant melanoma of skin; papillomas of bladder; brain tumors; mixed
salivary gland tumors; pinealoma.

1IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIllllllllIII-IIIII

IIIIIII::

1

Registry Name; New York State.

'4'
2.4

Describe how cancar death information is used in the registry:

All deaths

.

fznnhcanna!;(and in "Upstate" area with mention of cancer) are computer matched
previously not reported.
againat_:h§_3§gi§§gy_annually to obtain cases

2.5

:2:: census data is readily available to you? (years, levels of residence w

. 583. etc-): 1970 data by age, sex, race for minor civil divisions with

Expect similar data for l930.

populations by age and sex by town computerized.

2.6

To what degree is the registry data computerized? (years, files, plans, etc.)
lQSO-present with 2 basic files of:

l.

Archival (Cases diagnosed and/or reported 1950 69)

2.

Master

not
(Cases diagnosed and/or reported 1970 to present plus cases

known dead 1953-1969 for matching of incoming cases).

2.7

in 1980. (reports,
List the ways in which the registry data was used
of cases by site, sex,
number
of
tions
tabula
g
requests, studies, etc.): ggngin
and
justed rates; number of cases by sex,
and age with age-specific and age-ad

age for major sites by county.

r In Five
Data submitted for inclusion in Cance

Continents Vol IV (1973 1977).

n the
Basis for epidemiologio research both withi

incooperative projects with outside
Department and as collaborative and

ls.
l of Public Health and Medical Schoo
Vestigators, especially at Schoo

2.8

try
ties to analyze and process regis
Describe your present computing abili
data:
; 2
§1QQ E 2 dedicated di§k pggk gigg
COMPUTER EQUIPMENT: Eugzgnghs
t entry to Data Base System.
Hazeltine 2000 CRT's for direc

COMPUTER PERSONNEL:

ement of Data Base
1 Programmer responsible for manag

and tabulations.
and production of routine lists

ngements:
a 45a :ov service, describe arra
Department of Health.

Describe an

future plans:

N/A

Computer of the New York State

IIIIIIIIIIIII I

Registry Name:

-53.0

New York State

REGISTRY DEVELORENIS

3.1

Are any of the following items collected for the registry?
P - Planned)
N - Ho
(Y = Yes

Residence history............................................. Y \NW P
Occupational history.......................................... ', N P
.
Smoking hiszory......................,.......................

Fe:a1e history (parity, menopause, e:c.).................C....

,

Fazily history of c:::e:...................................... Y
Other (please Specify)

'

P

N, I

P

is coded:
If yes to any of the above, please describe how the data
Cigarette Smoker?

Present, Former, Never, Unk.

Occupation and Industry:

of
(1) Name and locality of firm or company (II) Kind

business Or industry (III) Usual occupation.

3.2

Please describe any future developments:
reports.

Publication of Scheduled annual

e.g., race/
Publication of selected variables in greater detail,

color tabulations, tabulations by marital status.

3.3

Are there any other comments that you may have?:

F°r

R°9istry th

31

collected as simple
New York State, it is essential to keep the information
ion as possible.
as possible to ensure as complete and accurate informat

86

°£

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII I

MONTGOMERY COUNTY
Registry Name: °h1°
Dete: Herch 9I 1981

CANCER REGISTRY SURVEY
GREAT LAKES BASIN
Please provide short answers to the questions that follow.

If a question or item does not apply, please indicate by a 'N/A'.

1.0

REGISTRY CHARACTERISTICS
ment or operation
Describe the current stage of registry develo
nel from
Registry stsrted in l95§. At thet time person
(when did 1; start):
own
its
hed
l
eech hospite
the registry went to the hospitels. By 1975

1.1

registry end sends weekly reports to the registry.

AnY°n3 dilSHO'ed

ics:
Describe the population coverage. size and characterist

1.2

hospitel is reported.
es heving cencer in e Montgolery County

Atteched sheet

describes the Montgomery County populetion.

ction techniques:
List the registry dete sources and colle

1.3

YEAR

DATA

STARTED

SOURCE

.tc.rin

I

1"1 V 11°7

1953

VOLUME

CURRENT

PER YEAR

YEAR

1981

1953

COLLECTION

THOD

boerd conference

:1; Tumor

once e week.

,

Pick-up end

delivery of cese report

forms between hospitels

1981

end centrel registry .

1953

1981

inst ; Iy
sppggxnewl
A

5" 311 b'th

1953

1981

of cencer s yeer.

Gr 35V1'V

1953

1981

for Montgomery County

1953

1931

t

Good 5".rit.n

Childrens

Describe any future plans:
counties.

12$ FolIow-up through

physicians end through

other county hospitels

esIH

E .

n '

\
\

diegnosed ceses

in other
Would like to include more hospitels

rens
with Hontgoeery County Vete
Hould like to resolve problems

rds end the Privecy Act.
Administretion Hospitel reco

1.4

rks, sbstrsctors,
l and their duties, (cleoversees registry.
Hes hospitel
List the registry personne
teer thst
Volun
.
etc.
ere voluners
ers
ramm
Ielb
ro
d
Doer
ans
r
s etistici
prectice. All Tumo
M DIéAL DIRECTOR )
i
teers.

No.

;

"

1

"

1

""
2

""
2

-

1

""

1

Dot 3
between Tumor
KHEIEIbtretive duties, Lieson

g22_33515

stry.
Boerd, hospitels end regi

Executive Director

mne

""" ' ""'

Supervisor

' ' - _
Pert-time Programmers

""""""""

g stry personnel.

pnys 1c lens .
uter dete entry
Volunteers who design comp

rarest:

computer
Enters dete on cerds for

Key-punch Operetor

plans:
Describe any future

'

re
.
itels end
followed for life through hosp

Pollowbup Clerks

H°" 11" Cl rk

e e supsrv s on o

records in
Works with vitsl stetistics

Montgomery County end Ohio records.

computer eepebilitiee.
Increese stetisticel end
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1.5

Registry Name:

How 13 th¢ r351.gry directed and funded?

Ohio

Twelve percent from United

seventy-eight percent earned income iron private trust fund.

by funds;

Directed by county

tumor Registry Board ends up of medical and lay residents of the cos-unity.

1.6

Describe houfthe data for the cancer registry is:
Abstract fore utilised.

COLLECTED:

c0939:

Copy of form attached.

At the Hospital of diagnosis.

PROCESSED:

Manual processing at the Central Registry.

Computer data processing

now in process.

VERIFIED (EDITED):

Abotracts are reviewed by Registry personnel.

looks out of order. the physician and/or hospital is called.

If anything

Ninety percent of

data is accepted as received.

VALIDATED:

Continuous crane checking between hospital registry end central

Registry personnel as to number and types of cases by week.

SIOKBD:

1.7

Abstract torn is filed alphabetically by name of case

Describe the follow-up techniques that are used by the registry:
physicians as to current status of diagnosed patients.

months for life of patient.

1.8

list from Registry.

1.9

Rave excellent cooperation from physicians.

Describe the quality control techniques used by the registry:

are reviewed upon receipt.

Provide estimates

L.tt r' in

Letters sent every six

Follow up list printed each month.

Abltrlc

Hospitals check

If they don t match, the matter is investigated.

for the following:

N'A

Z of registry cases are identified by death certificates (use the
number of death certificates only and the number ofdeaths that
were later investigated for cancer site confirmation; divide by
total incidence cases for the same year).

100

1 of registry cases have their diagnoses confirmed by histology
(exclude non-melanoma skin tumoure).

3,100 cases of newly diagnosed cancer for

88

1

(year)

MONTGOMERY COURT!
Registry Name:

'3'

DATA UTILIZATION

eoesaaeo
Registry Numbersesaoaasseeaseea-eesaaeseeasseesoo

-aaa
eees

..........
Case Number (for multiple primary sites)...............
Last
First

ossasOIOOOOI
namesaseasaaseeeasesoeseaassoeassasaefaoeseaaeae
O
aesooeeOIOO
eoeeseaa
easeoeea
toellIIt
eseasoea
.messaoa
giVEH

.
..........
iv n na
Second
?P¥§¥?IP¥I9ET"°" """"""'
mm 5min.317..........F9T.§¥
...............:::::::::::::::::::

Street address.................

city/town/CountYaeasaeaeessao-ueeleo

-o to.
eesaIn
saeaose-aoeouoeeae

se-aoaeoseas
State/ProvincesaeeeaeIaseeesea

sessealltliil
oesaaaeasa

..................
Zip/Postal code................................
......................
Date of birth..............................
......
Age at diagnosis...........................

................

.......
.....
Race/Netionality...........V§¥?§n.¥9§7¥3173s.9 K¥QWQ.

.....
......................
Marital status........................
.............
.......
.....
.....
.....
.....
.....
.....
Sex............
..................................
Date of initial diagnosis......
................................
Primary site.....................
.......

......
............
Histology...............................
...........
.....
.....
.
on...
rmeti
Method of diagnostic confi
Q¥EQX E
.Q¥.Q
..E!.
9?.§.
9¥;.¥
¥¥?.f
Paired organ invoxvement.......é§
.
.
..
.
.
....
.....
Size of tumour....
.1391.
.
t
Regional node involvemen
........
........
stage at diagnosis...........

....................

...............................
Date of first treatment...........
.
............................
....
....
First course of treatment...
...
....
....
2...
QW1Q
§Q§§
.QP.
QQ!9
Date of first recurrence...9¥?P¥.E
..........
............................
Subsequent treatment(s)....
........
....
....
....
....
....
....
....
Date of last contect/death...
....
Status......................

.....
........................

....

2
2 Z 2 z 2 2 Z 2 Z 2 2 Z 2 2
z z'z §yz 2:55 ;2:Z Z Z 2 Z

Are the following data elements used in the registry?
(Y 0 Yes,
N ' 0,.
P - Planned).

2.1

geek eee §©@@@ee©@@@a@@@@ W

2.0

OHIO

P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P

Other (Please specifyOx

red on computer at this
d, however this is not ente
Quality of survival is note
t or outpatient status.
Note is made of inpatien
are recorded.
time. Physicians names

2.2

dates of usage (e.g. SNOP
ng directory used and
Please indicate the codi

1972-1978, ICD9 1979+).

HISTOLOGY:

Edition. American
ture and Coding, 1968
Manual of Tumor Nomencla

Cancer Society

CANCER SITE;

sion
H-ICDA, 2nd Edition, 8th Revi

some or msmss:

RESIDENCE:

2.3

SEER Manual. Book 6

Entered as alpha language

istered:
t conditions are reg
cers or non-malignan
can
n
ski
t
wha
and
Describe how
istered
Benign tumors are reg
ered.
cancers to be regist
no not require skin
with same data taken.
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4;2.4

031°

Describe hon cancer death information is used in the registry:
for survival analysis

2.5

lasistry Nels:

"h" an". a.

race. sex. etc.):

t° 4 .

from dsteof disgnosis.

1' Iff

bu i

w

. $5

levels of residence,

Tyeéghuth e United States Census

of the Population, Deyton Standard Hetropolitsn Statistical Area.

2.6

Io uhst degree is the registry date computerized? (years, files. pleas, etc.)
Beck to 1967 on tape
Dsts goes beck to 1953

List the ways in which the registry data was used in 1980. (reports,
requests, studies, etc.):
To answer individual requests from hospitsls, physicians for number of csggs
by site.

2.8

Annual reports for tumor registryiboards.

Describe your present computing abilities to anslyre end process registry
data:

COMPUTER EQUIPMENT:

Internstionsl Business Mach

design and data entry by

COMPUTER PERSONNEL:

PonderosaSystems,

Incorporated.

Full-tine dsts processor, two pert tine progggggglexjp

Pondeross Systees, Incorporated stuff.

If fee for service, describe srrsngements:

"° '- D°n t'd 5! P°nd¢rolg_§19tell.

Incorporated staff.

pggcribg any futug. p1gngg

Finish current programsI

23.133 3.! .h.;;. :. -

break stsge down, more site specific, size of tuner, eore specs for physician
names - More sophisticated quslity control, i.e.. nov collect but do not code.

Need dots of recurrence.

Need more efficient way of collecting desth inggggetion.

90
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Registry Name:

'5'
REGISTRY DEWLOMNTS
3.1

Are eny of the following items collected for the registry?
(Y - Yes
N I No
P - Planned)
Residence

history..e....-

e

e

e

eeeeeeeeeeeoeeeeeeeee Y

Occupationsl history.....qd!:?. sg. q .ff.....................
Smoking history......nuwgl élsxqgitu wugfu '...u...

&

Female history (parity men su
et
.0
.
............. Y
Family history of cancér. ! ?§?99§§ ?z. Bf'tgqu l un......... Y 8
Other (please specify)

W'd'd'v'v

3.0

W10

If yes to any of the shove, please describe how the dets is coded:
Dete is not coded.

3.2

Please describe any future developments:

N° ' with "t b11'h'd d t"

like to demonstrete greeter utility of collected dete.

closest to e populetion based registry Ohio hes.

"° 1d

This registry is the

Therefore, the potentiel

d incidence dets.
exists for populetion besed ege, sex, rere edjuete

3.3

would b. 3" c to h'vf
have?:
may
Are there sny other comments that you
Hey.
same
ell registries gethering the same date in the

Registry Name:

Date:

ONTARIO
FEB. 20 1981
___._.__l_____

CANCER REGISTRY SURVEY
GREAT LAKES BASIN
Please provide short answers to the questions that follow.

If a question or item does not apply, plesse indicate by I 'N/A'.
1.0

REGISTRY CHARACTERISTICS
1.1

Describe the current stage of registry development or operation

F
V
T
T
N 19 9 AN 0
TAR
(when did it start):
RESEARCH
AND
TREATMENT
CANCER
ONTARIO
THE
EPIDEMIOLOGY AND STATISTICS,
FOUNDATION

1.2

Describe the population coverage, size and characteristics:
PEOPLE;

3 MILLION

LARGE MIGRANT GROUPS FROM U.K., ITALY, POLAND, GERMANY,

NETHERLANDS, HUNGARY, ETC.
1.3

List the registry data sources and collection techniques:
DATA
SOURCE

HOSPITAL SEPARATIONS
PATHOLOGY
FOUNDATION CLINICS
DEATH CERTIFICATES
OTHER HOSPITAL REGISTRIES

YEAR
STARTED

CURRENT
YEAR

VOLUME
PER YEAR

COLLECTION
METHOD

1904
"""
1972

1979
""""
1931

68,000
"""'
25,000

COMPUTER TAPE
CUPTES DT"
PATHOLOGY REPORTS

1939
---1950

1981
---1981

19,000
---16,000

1904

1931

ABSTRACT CARvs (1900+
------c0MPUT£RIZEv)
IBM cARvs, Now ON TAPE
'
ABSTRACT FORMS

Describe any future plans:

2,000

HEMATOLOGY DEPARTMENT RECORDS;

ALL DEATH

CERTIFICATES IN ONTARIO

1.4

List the registry personnel and their duties,

(clerks, sbstractors,

statisticians, programmers, etc.).

§o_.

gu_ci_e_g

Job Title

£L_

DIRECTOR 8 ASSISTANT

DIRECTION, RESEARCH 5 SERVICE

_L__

STATISTICIAN

GENERATE DATA FOR RESEARCH 5 SERVICE

£L_

CLERKS

CODING, DATA ENTRY, QUALITY CONTROL

_L__

MEDICAL RECORDS OFFICER

DIRECT CLERKS, QUALITY CONTROL

_§__

TROGRAMMERS

MAINTAIN DATA, PROGRAMMING, DEVELOPMENT

_1__

SECRETARY

CORRESPONDENCE, REPORTS

Describe any future plans:

A
ANOTHER EPIDEMIOLOGIST MAY BE INVOLVED ON

PART TIME BASIS
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Registry Name:

ONTARIO

How is the registry directed and funded?

UNDER THE DIRECTION OF THE ONTARIO

CANCER TREATMENT AND RESEARCH FOUNDATION;

A STATUTORY FOUNDATION SUPPORTED BY

CANCER CONTROL FUNDS FROM THE PROVINCIAL MINISTRY OF HEALTH.
1.6

Describe how the data for the cancer registry is:

COLLECTED:

USING PRECODED DATA ON FORMS OR COMPUTER TAPE.

NONE OF THE DATA

IS ACTIVELY COLLECTED BY THE REGISTRY STAFF.

CODED: .SOME ABSTRACTED DATA IS PRECODED BY CLERKS AND THEN ENTERED AT VIDEO
TERMINALS.

STANDARD CODING SYSTEMS ARE USED FOR SITE. PATHOLOGY AND RESIDENCE.

PROCESSED;

DIFFERENT SOURCE DATA FILES ARE PROCESSED AND NEWLY DIAGNOSED
EEAlEQ B! {QMEIIEEIZEQ REIQR

{ASES ARE

VERIFIED (EDITED):

[INKAGF TFPHNIOUFQ

ER
ALL DATA ENTRY OF RECORDS OR TAPE FILES UNDERGO COMPUT

EDITS ON VALID CODES, RANGES AND CONSISTANCY CHECKS.

RECORDS ARE
CODED WORK IS CHECKED AGAINST SOURCE RECORDS AND
TAPE UNDERGO QUALITY CHECKS
VALIDATED DURING SITE REVIEWS. SOURCE DATA ON

VALIDAIED;

mum PDFATET!

STORED:

;
MASTER FILE COPIES ARE STORED IN EXTERNAL VAULTS

MOST OF THE DATA

IS ON DISC AND BACKED UP ON TAPE.

1.7

1.8

1.9

registry:
niques that are used by the
Describe the follow-up tech

THE

__

ONE-HALF OF ALL CANCER CASES IN
FOUNDATION CLINICS ACTIVELY FOLLOW OVER
PASSIVE FOLLOW UP.
ONTARIO; THE DEATH FILE IS USED FOR
registry:
rol techniques used by the
Describe the quality cont

PROGRAMME

SPECIAL SURVEYS AND STUDIES;

CONTROLLED DATA ENTRY;

SITE REVIEWS;

WITH MULTIPLE SOURCES;

VALIDATION OF CODING WORK.

CROSS-CHECK

the following:
Provide estimates for

certificates (use the
are identified by death
2-5 I of registry cases
ber of deaths that
num
the
icates only and
number or death certif
mation; divide by
fir
for cancer site con
were later investigated
total

the same year).
incidence cases for

confirmed by histology
have their diagnoses
90 1 of registry cases
s).
our
tum
n
ski
(exclude non-melanoma

27,000

____Ky r)
case, of newly diagnosed cancer for _1:Z§
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Registry um: ONTARIO

'3'
DATA UTILIZATION

Are the following data elements used in the registry?

N - No,

P - Planned).

Registry Number-cooacne-on...ocuooooooooon-coooooo-o-pow-oceani
c.
primary .1te.)nooucoooclooooooo-o-oooco
Case Number (for
Last Munoaooconooiooooo-oooocoaoIoIooooeucoco-nooooooooooo
ooooo
First given name-cocoocooooooocoo-loco-ooneconcouoo-ooncc-nouloon
m...0.0.0.0....O CO'OOOUOOOIIIIOOloottll'OOIOOOOOO
Second given
nm...'..l0.... 0.0.1.....

. ....
C...l.....l..I II..........I

Street address-0..a...OIII0.0IIIOIOCOIIIIIDIOIICOCQIUOUCCCCGIIOIO

..........
City/town/county.......................................

..State/Province...........u.uu.uu.u...................utl
codeogololooaooanaaol-IoCacti.Clause-coooolnaooooaol

Zip/Postal

ooouo
Date Of birchoooaogo-o-cocoon-o-oo-ononeInoun-cococoonno-onn

Age at-diagnosis.................................................

Race/Nationality.................................................
.....
Marital status..............................................
sex-coonoa-oooacooonuoloooooooo-ceuo..-Ian-oouuooo

ocono-ooocoo-o

Date of initial diagnosis........................................
toao
Primary site-cocoooooooaConlooocaoooaoa-IooucnDuncan-altooooo

.............
Histology...........................................

Method of diagnostic confirmation................................
..
Paired organ involvement.......................................

....
Size of tumour...............................................
Regional node involvement........................................

Stage at diagnosis...............................................

Date of first treatment..........................................

Fitst course of treatment........................................
Date of first recurrence.........................................
Subsequent treatment(s)..........................................

Date of last contect/death.......................................
...
Status..............................................

Other (Please specify)! FAMILY HEALTH INSURANCE NUMBER; "TWE' b'F"su1zG$v,
PREVIOUS TREATMENT;

RADIOTHERAPY AND CHEMOTHERAPY;

m'vooeantm w vim w m m'vIvaEa 9«I~36)m'VQBEjNIw w w m

(Y - Yes,

zzzzzzzzzzzzzzzzzzzzzzzzzzzzz

2.1

99 9999999@@@@< ~88<®9v< ~<

.1

QUALITY OF LIFE INDEX (PILOT

STUDY).
2.2

(e.g. SNOP
Please indicate the coding directory used and dates of usage
1972-1978, ICD9 1979+).

HISTOLOGY:

1960-1978 MOTNAC (1968 EDITION)
1979+ ICD-O

1960-1978 ICDA-S

CANCER SITE:

1979+ ICU-9

STAGE OF DISEASE:

RESIDENCE:

1972~1978

TNM CLASSIFICATION SYSTEM

OWN 3 DIGIT ALPHA CODE (CITY OR COUNTY)

1979+ 4 DIGIT CODE (ONTARIO MINISTRY OF HEALTH)
2.3

are registered:
Describe how and wuat lain cancers or non-malignant conditions
1979+ ICU-9
MALIGHJH? MELALOMA; P i CANCERS - ONE FOR EACH CELL TYPE;

CODES 210-239 REGISTERED;

[SKINS ICD-173 WILL BE EXCLUDED FROM INCIDENCE

FILE FROM 1972+).
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Registry Name: ONTARIO

4'
2.4

Describe how cancer death information is used in the registry:

PASSIVE FOLLOWUP;

FOR

CANCER DEATHS wITHOUT SUPPORTING EVIDENCE ARE FLAGGED AND

USED IN THE REGISTRY.
2.5

What census data is readily available to you? (years levels of
ide
race, sex, etc.):
ALL PUBLISHED CENSUS DATA FOR ONTARIO SINCE P323; not,

COMPUTER DISC FILE HAS POPULATIONS BY YEAR, COUNTY, SEX AND 5-YEAR AGE GROUPS.

2.6

To what degree is the registry data computerized? (years, files, plans, etc.)

ALL DATA ARE COMPUTERIZED;

ALL ORIGINAL SOURCE RECORDS ARE RETAINED UNTIL

COMPUTER LINKAGE IS COMPLETED.

2.7

, .
List the ways in which the registry data was used in 1980. (reports
RESEARCHERS, CANCER
requests, studies, etc.): INFORMATION REQUESTS FROM

NEwS
REGISTRIES, CANCER CLINICS, GOVERNMENT, HOSPITALS, PHYSICIANS, PUBLIC,

MEDIA, ETC.;

SITE REVIEwS OF BREAST AND TESTIS;

ANNUAL REPORTS;

ANALYSES

HIC AREAS SUCH
OF CANCER MORTALITY IN MIGRANT POPULATIONS; CANCER BY GEOGRAP
(A COMMUNITY
AS MUNICIPALITIES BORDERING THE NIAGARA RIVER AND PORT HOPE
EXPOSED TO LOW'LEVEL RADIOACTIVE WASTES);

DATA FOR PLANNING MEDICAL RESOURCES,

CLINICAL TRIALS, AND EPIDEMIOLOGICAL STUDIES;

ASSISTING IN OCCUPATIONAL

FOLLOW-UP STUDIES; ETC.

2.8

ties to analyze and process registry
Describe your present computing abili
data:

DRIVES; ONE TAPE
COMR EQUIPMENT, POP U/34 wITH Two 300 MEGABYTE DISC
ON AN AMDAHL
uNIT (COMPUTERIZED RECORD LINKAGE IS BEING DONE EXTERNALLY
AT STATISTICS CANADA).
3 PROGRAMMERS
coma Know, I MANAGER, I SYSTEMS ANALYST AND

arrangements:
If fee for service. describe

UTILIZE IBM 360 AT UNIVERSITY

NOT REQUIRE PATIENT IDENTIFICATION
OF TORONTQ EUR RESEARCH THKT DOES
AND RESEARCH
THE ONTARIO CANCER TREATMENT
Describe any future plans:
UTERS
UNDERGOING A MAJOR UPGRADING. COMP
FOUNDATION'S COMPUTER SYSTEM IS
BE USED
ICS AND A LARGER COMPUTER WILL
WILL BE PLACED IN THE SEVEN CLIN
EMIOLOGY.
FOR THE CANCER REGISTRY AND EPID
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Registry Name:

'5'
3.4

95153y1______

REGISTRY DEVELOPMENTS

3.1

Are any of the following items collected for the registry?
P _- Planned)
N - No
(Y - Yes
ugide m

history.cor-003..no.Co0.01.0

o
.0.chooooooocooo-oooocol

oonnno-occocoon-ooh.
Occupational hiltoqoocooc.noon...nonooooc
ooaooooolococcluoco
history-occloc'ocuncouth-.oo-oolloc

Y

P

Y

P

Y

P

............... Y
Female history (parity. menopause, eta.).......
........ Y

P

P
......
Family history of cancer........................
CS MAV COLLECT THIS INFORMATION
Other (please specify) FOUNDATION CLINI

ON THE NEw COMPUTER SYSTEM

ibe how the data is coded:
If yes to any of the above, please descr
NG STATUS (CURRENT, PREVIOUS OR
LONGEST OCCUPATION (SIC CODES); SMOKI

NON-SMOKER);

;
PARITV AND MENOPAUSE ON SELECTED SITES

INDICATOR 0F

FAMILV HISTORV

3.2

Please describe any future developments:

DATA FROM SEVEN ONTARIO CANCER

CS AND THE ONTARIO CANCER INSTITUTE
TREATMENT AND RESEARCH FOUNDATION CLINI
BLE FORM; REGISTRV STAFF WILL SPEND
WILL BE TRANSFERRED IN MACHINE READA

MUCH MORE TIME ON QUALITY CONTROL.

3.3

may have?:
Are there any other comments that you
7;
AVAILABLE FOR THE YEARS 7969-197
SHOULD BE AVAILABLE FOR JUNE 798I;

INCIDENCE DATA IS READILV

ED AND
THE 7972-1976 DATA IS BEING LINK
I977 WILL BE LINKED SEPARATELV By

TWO
THE LAG TIME WILL BE DECREASED TO
SEPTEMBER I981 AND AND EVENTUALLV
OSES
IS INITIALLV COLLECTED FOR OTHER PURP
YEARS (SINCE WE RELV UPON DATA THAT
CAN
OTHERS); 1964-1966 INCIDENCE DATA
AND IS PROCESSED BY THE EFFORTS OF
THAT ALREADY EXIST.
BE RECONSTRUCTED FROM DATA SOURCES

NOTE 2.1

COLLECTED ON THE ONTARIO
THE DATA ON STAGE AND TREATMENT IS
DATION CLINIC PATIENTS ONLY.
CANCER TREATMENT AND RESEARCH FOUN
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3.31.;gy u.m¢: PA Cancer Registry
Date-a

-

_

-

CANCER REGISTRY SURVEY
GREAT LAKES BASIN
Please provide
_
short answers to the questions that fell .
If a question or item does not apply, please indicate b3". 'N/A'

REGISTRY CHARACTERISTICS
1.1

Describe the current stage of regiatr y development or operation
Pennsylvania's Registry is in a planning stage. Plgns
(when did it start):
Include pilot testing the registry later this year or early next year and
then beginning statewide operations.

1.2

Describe the population coverage. size and characteristics:
coverage:

P lnned

All Pennsylvania hospitals and laboratories would be required

to report all cancer cases in Pennsylvania.
tion techniques:
List the registry data sources and collec

mm
some:

ammo
m

m
M

vows:
m we

To be planned.

councnou

iiililié:

1.3

Hill

1.0

Describe any future plans:
graphic area.

1.4

Stage 2:

Stage 1:

Pilot test registry in limited geo-

e is 20.000
Statewide registry ' estimated volum

ding b.000
hospital case reports/yr.l yiel
laboratory reports and 60,000
ania residents.
cases of cancer among Pennsylv
abstracters,
l and their duties. (clerks,
List the registry personne
ned.
plan
be
To
).
etc.
statisticians, programmers,

g;
.._.

Duties

Job Title
.._.____________
-

___.__

-

____._.

____._.

-

o

____.___ - -

____.._

'

- --

nal
posed of one professio
A core Erolect team com
sion of Chronic Disease
Department of Health's Divi
each from the Pennsylvania
yegr
s will begin later this
pment and Health Statistic
elo
Dev
s
tem
Sys
l,
tro
Con
ry
nsylvania Cancer Adviso
operations with the Pen
to plan the registry s

ns:
Describe any future pla

nts.
Board and outside consulta

-2.
1.5

Registry Rene;

How is the registry directed and funded?

PA Canoe:

Registry

The registry is the responsibility

of the Pennsylvania Department of Health's Division of Chronic Disease Control
in the Bureau of Epidemiology and Diseeve Prevention.

1.6

the re istr

Describe how the

ate

COLLECTED;

Funds for pilot testing

will be e

or the cenz:rl ::;.1.::y°fiaiu y " 198"

N/A - p ro posed re 9 [5 try form is attached.

CODZD:

PROCESSED:

VERIFIED (EDlTED):

VALIDATBD:

STORID:

1.7

used by the registry:
Describe the follow-up techniques the: ere

None are

planned.

1.8

used by the registry:
Describe the quality control techniques

jmggggg1_______

reebst;ggtlgg_h9§nltgl____g_
quality control procedUres include registry staff
. and comguter editing f9;
records, matching registry forms with death records
invalid fields.
1.9

Provide estimetes for the following:

N/A

by deeth certificetes (use the
1 of registry ceeee ere identified
the number of deeths the:
end
only
ee
ficet
number of deeth certi
contiruetion; divide by
site
r
were lster investigeted for cence
.
yeer)
seas
the
for
ceses
ence
incid
totel
oees confirmed hy histology
1 of registry cesee heve their diegn
rs).
tumou
skin
me
eleno
non-m
ude
(excl

ceees of newly diegnosed cencer for

98

(yesr)

3.51.cry N.n.: PA Cancer Registw

'3
DATA UTILIZATION

P - Planned).

i
e8

trY?

Registry Number....u........u..un.u.un

Case Number (for multiple primary sites).....::::::....'...'...'name..............n..u..uu.....u-um}...

Last
First

given

......o....-..........
name.....o
name....

II

I

....-'.I.'....

.....
I
......'..
II'OIIOOI

.IOOOOI

soeoeeeoIn...Ino...no.oelocnoleeeoeo-eoeoeo-

Maiden name..................................

Street address...............................::....'.............
City/toun/county.............................. . ......'. .......
........III.Q
State/Province................................::::..
.'...
Zip/Postal code...................................::.....".
D te

Of

birth-lotto.-so.ee-eo-ocaInna-otoe-ecoo-

eoee:::::::::::::

..........
Age at diagnosis........................c..............

.........
Race/Nationality.......,............................
.......
Marital status...................u....~...........
SCXo-eeoee-ane-rn-II--011-one.

....

...
.....

-guceuue-aelo
..ne-no:eno-uooe-o-ece

........................
Method of diagnostic confirmation........
....

d K < K K K 4 K K K

...................
Date of initial diagnosis...n.................
.....................
......
......
...n..
.....l
......
site..
y
Primar
.............
..........
Histology................................n

....r.............
Paired organ involvement........c....

......

....
.................
Size of tumour...................a..........
...
......
......
.a....
......
o...l.
Regional node involvement.......

...............................
Stage at diagnosis................
.........o.....................
.....
.....
ment.
Data of first treat
.............................
.....
First course of treatment......
......

....................
Date of fir-t recurrence...............
........................
.....
.....
.....
s)...
Subaequent treatment(
........................
....
....
Data of last contact/death.......
St

tu'O 'III OQIO

OIIO DOII OOOI

I

OIVI l0.. .-IO

z zz 222 z zzez zzzeg ga

N ' No,

zz z zz z

(Y - Yes,

zzz zz

Are the £0110uing data elements u Bed in the r

&< N K t & <I<C< N < N K < K N

2.1

IOII OIO
O
OIOD
IIII IIIO COOO

NI

2.0

Other (Please apecifybt

2.2

usage (0.3. SNOP
directory uaed and date! of
Please indicate the coding
an iCD-O behavior
with
s
lasm
neop
of
ng
osed codi
1972-1973. ICD9 1979+)- Prop
code of 2 or higher.
HISTOLOGY:

CANCER SITE:

STAGE OF DISEASE:

RESIDENCE:

utilize
and non-residents who
Pennsylvania residents

and lainratories.
Pennsylvania hospitals

2.3

s are tegiltered:
-malignant condition
t akin cancers or non
Describe how and wha

ma

W

Ww
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.42.4

Registry Rene: PA Cancer Registry

Describe haw cancer death information is used in the rogiltry:

Proposed:

Monitor cancer incidence over time and stages of disease at inltiai diagnosis;

estabiish a data base for cancer
cer; prov

ea samp

ng

rame

revention studies; identify rare forms of can-

or surv va 5 stu

es; a

ua

v

n

g

§

iEais

:Q hainige', 5'

2.5

What census data is readily available to you? (years.
race, sex, etc.)z

2.6

To what degree is the registry data computerized? (yeers, files, plans. etc.)
We pian to computerize registry r system has to be decided upon.

'

2.7

(reports,
List the ways in which the registry dsts wes used in 1980.
requests, studies, etc.):
N/A

2.8

to ens].er end process registry
Describe your present computing ebilities
date:

COMPUTER EQUIPMENT:

'3" 37°

COMPUTER PERSONNEL:

If fee for service. describe errengexnents:

Describe any future pleas:

iOO

in

'5'
REGISTRY DEVELOMMS

Are my of the following item collected for the registry?
(Y - You
H - No
P - Plenned)
Residence h10t0ry.....uuu.."nun..."nun-noun...
Occupational hi toryeeeeeenu-u-eeeeenone...-.aeeeeaeeoqeeeepoo
Smoking history-ee-eeeeee-eooouoeeeeeooOcean's-enepI-eeeeqyone
Female history(p&r1ty, menopause, etch).........n...uuoiu
history of cancer... unuuunuu..."nun-nun

Other (please specify)

If yes to any of the ebove, please delcribe how the date 1- coded:

3.2

3.3

Please describe any future development-z

56° QUGSUO

the: you my have ):
Are there my other commute

1"

'd'd'd d'v

3.1

KKKOQvG

3 .0

Eggijtfy N.n.: PA Cancer Registry

Registry Name: Wisconsin
Dste:

2-27-81

CANCER REGISTRY SURVEY
GREAT LAKES BASIN

Please provide short answers to the questions that fol10w.
If a question or item does not apply, please indicate by 3 'N/A'.

REGISTRY CHARACTERISTICS
or operation
Describe the current stage of registry development
m became
The Wisconsin Cancer Reporting Syste
it start):

1.1

(when did

as a pilot
1978. Prior to this it operated
_A_atatg 1§g_§x§§gng§gg§5!71,

W h i t 1976.
Describe the population coverage,

1.2

size and characteristics:

1978 the population was
Wisconsin is covered. In
The entire population of
estimated to be 4,683,000.

tion techniques:
List the registry data sources and collec

1.3

DATA
SOURCE
Hospital

Med Rannlds
Tumor
Registries
Hospital

D.P. Dept.
"Central"
D.P. System*

COLLECTION
METBOD

YEAR
STARTED

CURRENT
YEAR

VOLUME
PER YEAR

1976

__12§1__

9500

Neoplasm Report Form

1976

1981

4600

Copies of abstracts

1976

1981

2100

Tape

1976

1979

2700

Tape

Describe any future plans:

July, 1980.
a number of hospitals but ended
* This "central" system served

Duties

Job Title

LLI?

1.4

D.P. or manual systems.
ess of converting to other
The hospitals are in the proc
_
s.
ract
abst
iving copies of
Th the interim we are rece
s,
sctor
sbstr
ks,
(cler
s,
their dutie
List the registry personnel and
.
statisticians, programmers, etc.)

ns of the System
Responsible for the operatio

Research Analyst

rt forms
Manual processing of repo

Clerical Assistant

I

1.0

-

____._._

-

Describe any future plans:
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.2.

4

How is the r egistry directed and funded?

1.5

The System is within the Bureau of

H ealth Statistics and is funded with State General Purpose

1.6

Wisconsin

Registry Name;

Revenue funds

Describe how the data for the cancer registry isThe data are collected either on the Neoplasm Report Form (completed

COLLECTED;

by the Medical Records Personnel), or on tumor registry abstracts, or by
tape.
CODED:

of
The data are coded in the Central Office by hand using the Manual

Site and Histologic
Tumor Nomenclature, the SEER program's "Codes for Primary
Codes".
Type II and the U.S. Dept of Health's "Geographical Location
paocgssgp;

The report forms are

inforsimply coded and editted while the

a report form
abstracts is transferred onto
mation on the tumor registry
sary and added to
on tape are converted if neces
and then processed. The data

the data base.
VERIFIED (EDITED):

in addition to the manual
There are computer edit checks

editting done.

VALIDATED:

STORED:

file. Back up
is merged onto the master
On a quarterly basis the data

kept for five years.
the original forms are
tapes are created and

7

1.8

1.9

registry:
niques that are used by the
Describe the follow-up tech

Since this

low-up is done.
system no active fol
incidence reporting
ed
bas
n
tio
ula
pop
a
is
to the data base.
certificates is added
Information from death

techniques used
Describe the quality control

by the registry:

The 60d1n§

bstracting study
is reviewed and a rea
the Central Office
and editting done in
ually.
ords is completed ann
of a sample of rec

the following:
Provide estimates for

*

e the
th certificates (us
are identified by dea
ths the:
dea
Z of registry cases
of
ber
num
the
icates only and
by
number of death certif
confirmation; divide
ted for cancer site
iga
est
inv
er
lat
e
wer
same year).

for the
total incidence cases

93

firmed by histology
e their diagnoses con
1 of registry cases hav n tumours).
oma ski
(exclude non-melan

gnosed cancer for
15400 case. of newly dia

1979

(year)

for this
ningful percentage
ung" to provide a mea
"yo
too
is
tem
Sys
* The
question.

103'

g1

Registry Name:

'3'
DATA UTILIZATION

010...
Emcee...-0|ObeIooooeeto tiolootoeeeonlooe.snlueeeoloeI

First given gmeseeeoeoeo-eeeeeloloneosee-eeeeeeeeu-eeosesesnoool
Second given ham...-\eoooveonee-enl-e000cooleeoeeoeeeeoon-DIIOOC
Maiden

nameleseeeeeeoeseases-ensee-aeh-oeeeeoeogoose-.eoe

oenos-oo

Street address...............................................-...

......n...
City/COW/county.....nnun-nun ..-.............
State/PIOV1BCE............u....-..--......u.......

.....no..c-o
...

Date

birthuntllgototOICOOOIII'OOOIOOIOOIIIloo

of

OIOI
ncooiltoullQO

..........
Age at diagnosis.......................................

.............
Rece/Nationality....................................
.....
....
Marital status..............,...........................
sex-eneeoes-oneonIns-sellsuse:ooseseeoce

age-essence
oo-oeeoesvsest

.
Date of initial disgnosis.......................................
Primary

site...e.oneout!0eelOIIIOIOOOOIIIIooIIeO

OIODO
OItIOOOOIOOI

.............
Histology...........................................
....
Method of diagnostic confirmetion............................
.................
.......
.......
.......
ment...
involve
organ
Paired
....
.....
Size of tumour..........................................

.........
Regional node involvement...............................

........
Stage at diagnosis.......................................

.........
Date of first treatment.................................

..............
First course of treatment..........................

.........
Date of first recurrence................................
.....
.......
.......
.......
.......
.......
nt(s)..
Subsequent treatme

..........
Date of last contact/death.............................
......

............
Discharge Status........................

.......
..........

5 5"<'< 5 ! $ 3"4" visas xa 51:1 F1'<l

Zip/Postal code..................................................

M W m'v M M

Last

'6 M M

Case Number (for multiple primary sites).........................

t vivit !$l li

Registry Number....unuu..nunuu..-....u.n.....n.u.u.

V M W m M M M W M m M W W M U W M 1

Are the following data elements used in the registry?
(Y - Yes,
N - No,
P - Planned).

22:2 2 z z z z :ggzz

2.1

2 z u a z z z 2;: ugz z 2 z z z z u

2.0

Wisconsin

P- death
P
only

_ Other (Please specify9:

physician,
Name of reporting hospital, follow up

dates of admission & discharge,

al?, is this the.on1y~primary?, has
is case diagnosed at the reporting hospit

_the patient been seen elsewhere?
used and dates of usage (e.g. SNOP
2.2 Please indicate the coding directory
schemes are l976 Present
g
codin
1972-1978, ICD9 1979+). All
HISTOLOGY:

Manual of Tumor Nomenclature and Coding

CANCER 5113;

ype"
SEER's "Codes for Primary Site and HistglggiEkT

STAGE OF DISEASE:

ing
"A Guide for the Tumor Registry Secretary in Record

ry
Stage" published by the California Tumor Regist
RESIDENCE:

2.3

Location Codes"
U.S. Department of Health's "Geographical

Describe how and what

are registered:
skin cancers or non-malignant conditions

ted and no information on
Only data on malignant melanomas are collec
non-malignant conditions is required.

104"

sin
Registry Nana: Wiscon

.4-

Lao-m

Describe how cancer death information is used in the registry'

2.h

icate are added to the incidence
Certain data elements from the death certif
records or used to create a record.

2.5

levels of residence,
What census data): is readily available to yOu? (years,
county of residence,
r ce sex, etc
Ethnic groupL sex, marital status,

age (calculated from birthdate)

2.6

erized? (years, files, plans, etc.)
To what degree is the registry data comput
cted through the
In addition to the data colle

All data are computerized.

incidence information
tapes containing incomplete
statewide system there are
d on a somewhat voluntary
This information was collecte
from earlier years.
basis.

2.7

orts, stry data was used in 1980. (rep
List the ways in which the regi
requests, studies, etc.):
The

'ncer in Wisconsinll978

d; numerous data
annual report was complete

answered; quarterly
archers and planners were
requests from health rese
a
r cancer experience; and
hospitals detailing thei
reports were sent to the

was completed.
referral pattern study

2.8

istry
analyze and process reg
computing abilities to
Describe your present
data:
COM?UTER EQUIPMENT:

IBM 370 model

-.

coMyUTER pERSONNgL;

3033

m.-.

0i5)
ce of information Systems§
Access to the State's Offi
-0»...- .. Juan. m. . u.-

personnel

cribe arrangements:
If fee for service, des
programmers'
m»W

015
There is a charge for

time.

- u..- ..-v .v. ,0- m..- ..s I...
»uu~- m-

a). ..

0 ..-

plans:
Describe any future
. w mn 0

M.,
.wrmrm..._. .--.m

-M_-Mw.

W... "mop..." H - r

e M. M. a, m...

u..u..._r,ru

. V

an ...

w.-...-,.-.MM on
...u .4. r e m. .. V. "n. .
~.. mm... -.~,..y-_ .. em'u-I .aaaw..-a-»i- .._.
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Registry Name:

Wisconsin

REGISTRY DEVELOPMENTS

OOI.."....'....

Y

Smoking history-00.030.000.000...tee-clonoo-ooo obltooooooooo
c

Y

Female history (parity, menopause, etc})...................... Y
Of

cancer.....on...c..o.............nu..-....

Other (please specify)

Y

ww

historytiuloou.0.0.IIIIOOOQI'OI.IIQO

Occ upa tio nal Y

ww

Are any of the following items collected for the registry?
(Y = Yes
N = No
P - Planned)

w

3.1

Z a mesa:

3.0

If yes to any of the above, please describe how the data is coded:

3.2

Please describe any future developments:

A conversion to the ICD-O coding

scheme for primary site and histology is under consideration.
a

Also, a change

in the unduplication process of the System is being studied.

3.3

Are there any other comments that you may have?:

Enclosed is a two page

summary of the Cancer Reporting System which may provide additional
information.

If you have any further questions you

maycontact Mary

:

Fischer at (608) 267 7141 or at Bureau of Health Statistics, P.0. Box 309,

{

Madison,Wl

53703.

APPENDIX G
GREAT LAKES PROJECT - DR. LEONARD SCHUMAN
UNIVERSITY OF MINNESOTA
§U.S. EPA FUNDING}
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GREAT LAKES PROJECT
UNIVERSITY OF MINNESOTA
FUNDED BY THE U.S. ENVIRONMENTAL PROTECTION AGENCY
The Departments of Epidemiology and Environmental Health, University of
Minnesota, are currently involved in a feasibility study to assess the
potential health risks associated with organic contaminants in the Great Lakes
Basin. The concern for possible human exposure to organic chemicals arises
from their physico-chemical properties which permit biomagnification in food
chains and their persistence in the environment.

We have selected as an indicator of organic contamination the chlorinated
hydrocarbons such as PCBs, DDT and dieldrin. Both public and private sources

have been contracted for data collection regarding the levels of these

contaminants in the environment of the Great Lakes. Reviews of these data
sets have identified several "problem areas" typically associated with point

sources (i.e., industrial and municipal dischargers).

Non-point sources

(i.e., atmosphere) have also demonstrated a significant contribution to

organic contaminant levels in the Great Lakes Basin.

Biomagnification of organics through the aquatic foodchains may provide
one of the most direct routes of potential exposure to human populations.
Thus, it has been hypothesized that a potential human exposure may exist via
consumption of contaminated fish. This possibility has been explored by
Humphrey and his associates. Their findings suggest that there could be long
term accumulation of these materials in populations consuming large quantities
of fish.

However, no difference was noted in the health status of high versus

low level fish consumers. The study design utilized by Humphrey, gt_al., (see
Appendix G to these Proceedings) does not negate the possibility of adverse
latent effects from long term low level exposure.

e.
The focus of our project has been to assess this latter form of exposur
animal
in
ens
Chlorinated hydrocarbons have been implicated as carcinog
studies. We have therefore undertaken an analysis of site-specific cancer
mortality rates for the years 1950 to 1969 by the degree of geographical
contiguity with the Great Lakes. The hypothesis of this evaluation is that

those populations closer to the Great Lakes may experience a greater exposure

potential to organics and therefore may experience a higher cancer
morbidity/mortality.

of
To evaluate the potential health risks associated with the consumption

Great
contaminated fish we have compiled a cohort of fish consumers from the
Lakes region. Several subgroup populations have been identified to serve as
pilot study
potential cohorts. The Great Lakes project staff has initiated a
a small
on
nnaires
questio
and
s
protocol
to evaluate several epidemiologic
The
Lakes.
Great
the
from
en
fisherm
ial
sample of randomly selected commerc
of
ness
complete
the
upon
based
was
decision to use this occupational group
Natural
records available from the eight Great Lakes State Department of

Resources (DNR) offices.

Following the completion of this pilot study the

.
epidemiologic methods demonstrating the greatest effectiveness will be
fishing
ial
commerc
the
with
ted
utilized to evaluate all individuals associa
industry.
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The Great Lakes staff are also exploring the possibility of applying a
similar protocol to sport fishermen in the Great Lakes Basin. Several state
DNR officials have been contacted to elicit joint cooperation in sampling
sport fishermen based on current license holders. Discussions have been held
with the Wisconsin DNR for joint participation in their proposed 1982 sport
fishing practices survey.
A visit to the Baltimore Public Health Service Hospital has been scheduled
for the purpose of establishing a nonconcurrent prospective study of Great
Lakes commercial fishermen utilizing their services.
Summaries of these and future activities will be forthcoming. Further
questions regarding the specific approaches and results of the above projects
should be addressed to the principal investigators.

llO

APPENDIX H

FIELD STUDIES ON SELECTED

MICHIGAN POPULATIONS - DR. HAROLD E.B. HUMPHREY,
MICHIGAN DEPARTMENT OF PUBLIC HEALTH

TIT

FIELD STUDIES OF SELECTED POPULATIONS WITHIN THE GREAT LAKES BASIN
Michigan

In response to chemical contamination episodes, the Michigan Department of
Public Health has initiated two major epidemiologic investigations involving
over 7,000 persons in order to collect information concerning the impact of
halogenated biphenyl exposure on human health.

1.

Long Term Study of Human Health Consequences of Polybrominated Biphenyl
Exposure. Dr. Harold E.B. Humphrey, Project Director.

Citizens of the State of Michigan were inadvertently exposed to
polybrominated biphenyl (PBB) through contamination of farm animals
s selected
and consequently, food products. A cohort of 4,600 person
d in a
enrolle
been
have
e
on the basis of greatest presumed exposur
erm human
long-t
the
te
evalua
to
multi-year prospective study in order
of
State
the
in
s
person
1,500
health impact. A comparison group of
Serum
el.
parall
in
Iowa has been enrolled and will be evaluated
concentrations of P88 are measured periodically to monitor body
ted in
burden and the occurrence of major health events are evalua
and
pment
detail with particular attention being paid to the develo
es.
site of cancer and the development of other chronic diseas

2.

in the Great Lakes.
Evaluation of Humans Exposed to Water Borne Chemicals
Dr. Harold E.B. Humphrey, Project Director.
fish are
Persons who consume significant quantities of Great Lakes
aquatic environment.
exposed to chemical contaminants present in the
over 500 persons
Expanding on an earlier investigation, a cohort of
comparison group of 500
who consume sport caught fish and a matched
line have been enrolled
persons residing along the Lake Michigan shore
aminants found in fish
in a study which will attempt to relate cont
s. Human blood
with human exposure, health effects and life event
ally measured;
odic
peri
be
will
ants
levels of PCB and other contamin
s in fish meals
fish consumption will be monitored and residue levelwith body burden.
ion
elat
corr
and
s
quantitated for exposure estimate
blood over time
Longitudinal comparisons of contaminant levels in
on highly
cted
condu
will be made. Clinical evaluations will be
es in health
chang
mine
exposed subsets of the cohort in order to deter
tional
Addi
norm.
the
or physiologic function indicators away from
y high
tiall
poten
evaluation groups will be recruited from sites of
exposure in the Great Lakes basin.
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JOINT SCIENCE ADVISORY BOARDéWATER QUALITY BOARD IJC COMMITTEE
N THE

Y
ASSESSMENT OF HUMAN HEALTH EFFECTS OF GREAT LAKES WATER QUALIT

Mr. J.R. Hickman (Chairman)

Director, Bureau of Chemical Hazards
Health and Welfare Canada
Environmental Health Centre
Ottawa, Ontario

Dr. R.W. Durham (Until March 1981)
Applied Research Division
Canada Center for Inland Waters
Dept. of Fisheries and Environment
Burlington, Ontario

Dr. G.C. Becking, Chief
(Acting Chairman, Effective June 1980)
Environmental Toxicology Division
Dept. of National Health and Welfare
Environmental Health Centre
Ottawa, Ontario

Dr. H.L. Falk
Associate Director for Health
Hazard Assessment
N.I.E.H.S.

Dr. G. Berg, Chief (Until March 1981)

Environmental Health Institute
Division of Laboratories and Research

Biological Methods Branch
Environmental Monitoring & Support Lab
U.S. Environmental Protection Agency
National Environmental Research Center
Cincinnati, Ohio
Dr. Rita Bogoroch
Health Effects Program Director
National Council of the Paper Industry
Air and Stream Improvement (NCASI)
New York, New York
Dr. N. Chernoff
Health Effects Research Lab
U.S. Environmental Protection Agency
Research Triangle Park, N.C.

Research Triangle Park, N.C.
Dr. Wolfgang Fuhs, Director

N.Y. State Department of Health

Tower Building, Empire State Plaza

Albany, New York

Dr. Rolf Hartung (Until March 1981)
School of Public Health 1
University of Michigan
Ann Arbor, Michigan
Mrs. Ann H. Vajdic

Microbiologist
Water Technology Section
Pollution Control Planning Branch
Ontario Ministry of the Environment
Toronto, Ontario

Dr. A.P. Gilman (Eff. March 1981)
Toxicologist

Dr. James H. Day
Department of Medicine
Queen's University
Kingston, Ontario

Environmental Health Directorate

Dept. of Health & Welfare
Ottawa, Ontario

)
) Dr. Daniel E. Williams (Eff. March 1981
Dr. Robert F. Spengler (Eff. March 1981 Medical Consultant
logy
Division of Environmental Epidemio
ice
Bureau of Disease Control & Lab Serv
Michigan Dept. of Public Health
Lansing, Michigan

Assistant Head

cs
Division of Epidemiology & Statisti
The Ontario Cancer Treatment and
Research Foundation
Toronto, Ontario
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ASSESSMENT OF HUMAN HEALTH EFFECTS OF GREAT LAKES WATER QUALITY

(Continued)

Dr. S.I. Shibko, Chief (Eff. March 1981)
Contaminants & Natural Toxicants
Evaluation Branch
Division of Toxicology
Food & Drug Administration
Dept. of Human Health Services
Washington, D.C.

.

Observers
Mr. Joseph Prince
Technical Support Section
U.S. Environmental Protection Agency
Region V, Water Division
Chicago, Illinois

Mr. Vacys Saulys, Acting Chief

SAB Liaison Members

Remedial Programs Staff

Hooker Chemical

Chicago, Illinois

Dr. Mitchell R. Zavon (Until Jan. 1981)
Medical Director
Niagara Falls, New York

Dr. Harold E.B. Humphrey (Eff. Jan. 1981)

Great Lakes National Program Office
U.S. Environmental Protection Agency

3

.
:

Secretariat Responsibilities

Dr. A.E.P. Watson

Environmental Epidemiologist

Research Scientist

Dept. of Public Health

International Joint Commission

l

}

Great Lakes Regional Office

State of Michigan

Windsor, Ontario

-<
Jaw

Lansing, Michigan

for the

JOINT SCIENCE ADVISORY BOARD/WATER QUALITY BORD
IJC COMMITTEE ON THE ASSESSMENT OF HUMAN HEALTH EFFECTS
OF GREAT LAKES WATER QUALITY
The Committee will take the following under its purview:

l.

Lakes
assess the risk to health posed by contaminants in the Great

ecosystem;

2.

review action levels and guidelines for selected substances;

3.

,
provide to the International Joint Commission through its Boards
interpretation and consultation on health matters; and

4.

maintain awareness of current advances and knowledge as they relate
to human health aspects of the Great Lakes ecosystem.

wet»- a...

TERMS OF REFERENCE
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